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Standard of care: how can 
we safeguard it?
Colman	SC	Fung	馮兆璋，William	CW	Wong	黃志威	
	 With	the	Government’s	healthcare	reform	consultation	document,	“Your	
Health,	Your	 Life”1	 and	 the	 recent	 campaign	 promoting	 Family	Medicine	
and	 Primary	Care	 as	 the	 first	 point	 of	 contact	 and	 for	 continuity	 of	 care,	
it	 is	 likely	 that	 the	 demand	 of	 primary	 healthcare	 service	will	 increase;	
therefore	 there	 is	 a	 continuous	 pressure	 for	 an	 effective	 and	 efficient	way	
to	 deliver	 high	 quality	 care	within	 the	 limited	 resources.	 In	 this	 issue	 of	
The Hong Kong Practitioner,	 a	 pilot	 study	 on	 clinical	 risks/outcomes	 of	 a	
“Repeat	 Prescription”	 programme	 tries	 to	 answer	 the	 question	 of	whether	
repeat	 prescribing	 could	 potentially	 be	 beneficial	 and	 feasible	 in	 our	 public	
primary	care	setting.	
	 Worldwide,	 there	 is	 no	 single	 best	 method	 of	 delivering	 repeat	
prescriptions.	 In	 some	 countries,	 such	 programmes	 are	 led	 by	 nurse	
practitioners;	 others,	 are	 led	 by	 pharmacists	 or	 dispensers.	 For	 example,	
in	 the	United	Kingdom,	 patients	 under	 the	National	Health	 Service	 can	
get	 a	 repeat	 prescription	 online	 and	 choose	where	 they	want	 to	 collect	
the	medicine	 and	 from	which	 selected	 pharmacy	 or	 have	 the	medicine	
delivered.2	Questions	 such	 as:	 "Who	would	 be	 in	 a	 position	 to	 review	 the	
patients	 if	 it	 is	 not	 the	 doctors"	 or	 "When	 should	 the	 patients	 be	 reviewed"	
and	issues	such	as	refill	adherence,3	need	to	be	addressed.	
	 The	 first	 assumption	 for	 such	 arrangement	 is	 that	 only	 stable	 patients	
can	receive	repeat	prescriptions.	But	 then	what	 is	 the	universal	definition	of	
being	“stable”?	Can	“stable”	conditions	be	readily	assessed	by	 the	available	
health	parameters	and	not	changed	with	time?	
	 Another	question	is	what	advantages	and	limitations	are	associated	with	
the	 additional	 service	 of	 repeat	 prescriptions	 provided	 by	 other	 healthcare	
professionals	 such	 as	 pharmacists	 or	 nurse	 practitioners	 versus	 follow-ups	
with	 family	 doctors	 at	 longer	 intervals	 and	 having	 longer	 drug	 duration.	
Subsequent	 questions	 are	 how	 long	 before	 a	 doctor	 should	 review	 a	 patient	
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with	 chronic	 disease	 even	 if	 the	 condition	 is	 stable,	 and	
what	 needs	 to	 be	 done	 at	 each	 follow-up	 consultation.	
Clinical	 judgment	and	share	of	 responsibility	as	 to	which	
patients	can	 receive	 repeat	prescribing	without	 seeing	 the	
doctors	needs	to	be	clearly	spelt	out.
	 One	 po t en t i a l 	 d r awback	 i s	 t ha t	 wh i l e	 r epea t	
prescriptions	may	help	solve	 the	problem	of	 long	waiting	
time	to	see	a	doctor,	the	doctor-patient	relationship	can	be	
affected.	Apart	 from	 ensuring	 that	 the	 patient’s	 condition	
is	 clinically	 stable	 and	 achieving	 health	 parameters	
targets,	what	 else	 can	 or	 should	 be	 done	 at	 a	 doctor’s	
consultation?	 During	 the	 sharing	 session	 in	 a	 recent	
teaching	 of	 a	Master	 course	 at	 the	University	 of	Hong	
Kong,	 a	 patient	with	 diabetes	mellitus	 for	more	 than	 10	
years	 and	was	 known	 to	 be	 under	 “stable”	 condition	was	
asked	 if	 she	would	 prefer	 to	 see	 a	 doctor	 or	 a	 nurse	 for	
follow-ups	 for	 her	 diabetes	mellitus.	 She	 chose	 to	 see	 a	
doctor,	 as	 it	 would	 give	 her	 a	 sense	 of	 reassurance.	 It	 is	
well	known	 in	 the	 literature	 that	 the	presence	of	 a	doctor	
could	 act	 as	 a	medicine,4	 and	 the	 effectiveness	 of	 such	
an	 event	 is	 based	 on	 the	well-established	 doctor-patient	
relationship.	On	 the	other	hand,	 some	patients	may	value	
more	the	holistic	and	comprehensive	care	provided	by	the	
primary	 care	 team	 instead	 of	 just	 care	 provided	 by	 one	
single	 doctor.	Thus,	 research	 studies	 taking	 into	 account	
patients’	 perspectives	 are	 required	 in	 the	 local	 setting	 in	
order	 to	 help	 pave	way	 for	 the	most	 appropriate	 primary	
care	delivery	model.	
	 Another	 argument	 is	 that	 if	 ”repeat	 prescription”	
can	 save	 some	 time	 for	 the	 doctor,	 the	 doctor	 can	 spend	
more	 time	with	 patients	 on	 some	 other	 tasks	 such	 as	
on	 lifestyle	 assessment	 or	 smoking	 cessation,	 which	
is	 the	 focus	 of	 another	 article	 in	 this	 issue.	While	 the	
detrimental	 health	 effects	 of	 smoking	 have	 been	 proven	
beyond	 doubts ,	 i t	 was	 found	 that	 the	 recording	 of	
smoking	 status	 and	 details	 about	 smoking	 cessation	 and	
counselling	 advice	were	 poor,	 that	 these	 are	 not	 even	
coded	in	the	Clinical	Management	System.	In	this	article,	
it	 also	 shows	 that	 a	 simple	 audit	 exercise	 not	 only	 can	
identify	 weaknesses	 in	 our	 routine	 care	 but	 can	 also	
potentially	 bring	 improvements	 in	 our	 standard	 of	 care.	
This	 audit	 is	 one	 example	 of	 translating	 theory	 (e.g.	 the	
5A’s	 framework	 in	 smoking	 cessation)	 into	 practice.	
Although	 the	 number	 of	 smokers	who	 quitted	 smoking	
was	 not	 the	 main	 target	 in	 this	 audit	 exercise,	 i t	 is	
encouraging	 to	 see	 that	 there	were	 four	who	managed	 to	
quit	 smoking	 in	 the	 second	audit	 cycle	compared	 to	none	
in	the	first	cycle.	
	 The	 third	 article	 also	 looked	 at	 how	 theoretical	
evidence	 could	 be	 translated	 into	 clinical	 practice.	
The	 paper	 d i scussed	 how	 the	 f ami ly	 doc to r s	 can	
translate	 the	 Reference	 Framework5	 recommendations	
on	 hyper tens ion	 care	 in to	 da i ly	 c l in ica l	 p rac t ice .	
The	 reference	 framework	 is	 a	 consensus	 document	
endorsed	 by	 various	 stakeholders,	 including	 academic	
and	 profess iona l	 bod ies ,	 a s	 the	 mos t	 appropr ia te	
and	 feas ib le	 appl ica t ion	 of	 ava i lab le	 ev idence	 in	
pr imary	 heal thcare	 in	 Hong	 Kong.	 The	 Reference	
Framework	 aims	 at	 providing	 a	 common	 reference	
to	 guide	 and	 coordinate	 healthcare	 for	 patients,	 from	
all	 healthcare	 professionals	 across	 different	 sectors	
for	 the	 provision	 of	 continuous,	 comprehensive	 and	
evidence-based	care	 for	hypertension	 in	 the	community.	
As	 the	 reference	 framework	 is	 now	 accepted	 by	 all	
hea l thcare	 profess iona ls ,	 mul t i face t	 s t ra teg ies	 to	
actively	 engage	 primary	 healthcare	 professionals	 to	
adopt	 the	 recommendat ions	 wi thin	 the	 f ramework	
are	 the	 key	 for	 successful	 implementation6	 and	 worth	
further	 exploration.	 Following	 the	 recommendations	
within	 the	 framework	 helps	 to	 safeguard	 our	 standard	
of	care	while	 the	 individual	needs	and	circumstances	of	
each	 patient	must	 be	 taken	 into	 account	 by	 the	 treating	
doctor.	
	 Whi le	 fami ly	 doc tors	 a re	 t ry ing	 the i r	 bes t	 to	
improve	 the	 objective	 health	 outcome	 indicators	 such	
as	 blood	 pressure	 and	 body	 mass	 index,	 f lexibil i ty	
in	 c l inical	 pract ice	 must	 be	 a l lowed	 because	 each	
pat ient	 i s	 an	 individual	 and	 the	 management	 p lan	
cannot	 be	 simply	 taken	 out	 of	 one	 same	mould.	As	 a	
family	 doctor,	 who	 understands	 patients’	 individual	
c i rcumstances	 and	 needs ,	 he lp ing	 the	 pa t ien t s	 to	
identify	 barriers	 and	 negotiate	 achievable	 targets	 are	
essential	 steps	 in	 successfully	managing	 their	 chronic	
diseases.	
	 While	 family	 doctors	 are	 working	 hard	 to	 raise	
the	 standards	 of	 care,	 they	 should	 also	 enable	 and	
equip	 their	 patients	 so	 that	 patients	 can	 take	 up	more	
responsibility	 and	 take	 good	 care	 of	 themselves.	 Self-
care	 and	 patient	 enablement	 are	 other	 areas	 that	 family	
doctors	 can	 focus	 on	 and	 help	 their	 patients	 manage	
their	 chronic	 diseases,	 especially	 if	 some	workload	 of	
the	 doctors	 such	 as	 writing	 repeat	 prescriptions	 can	 be	
shared	 out	 by	 other	 health	 professionals	 like	 nurses	 or	
pharmacists	 who	 are	 actually	 within	 the	 same	 primary	
care	 team.	n 	
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The University of Hong Kong
Family Practice Attachment for Medical Students
The	Department	of	Family	Medicine	and	Primary	Care	of	the	University	of	Hong	Kong	is	actively	recruiting	family	
doctors	who	are	prepared	to	take	students	into	their	practices	for	teaching	purposes.	 	During	the	family	medicine	
junior	clerkship,	each	student	is	required	to	spend	some	time	attached	to	a	family	doctor	in	the	community.		These	
attachments	are	on	a	one-to-one	basis,	and	are	scheduled	at	regular	intervals	throughout	the	academic	year.		Each	
family	practice	(FP)	teacher	will	have	a	minimum	of	two	students	attaching	to	his/her	practice,	each	for	2	half-day	
sessions	during	a	9	week	period.
Most	doctors	find	that	teaching	in	their	practices	is	a	rewarding	experience,	and	the	satisfaction	gained	often	more	
than	compensates	for	the	minor	disruption	to	the	practice.		Those	who	volunteer	to	teach	will	be	given	an	honorary	
academic	appointment	at	the	University	of	Hong	Kong.		Appropriate	CME	and	CPD	accreditation	may	be	awarded	
by	the	Quality	Assurance	and	Accreditation	Committee	of	 the	H.K.C.F.P.	 towards	 the	award	of	 the	Certificate	
of	Quality	Assurance.	 	Our	honorary	 teachers	are	entitled	 to	use	our	University	facilities	 including	the	 library,	
computer	access	to	the	Internet	and	the	sports	club.
Fellows	and	members	of	 the	Hong	Kong	College	of	Family	Physicians	 are	most	 eligible	 to	 contribute	 to	
undergraduate	medical	education	in	this	way,	and	enquiries	from	other	doctors	would	also	be	welcome.
Please	complete	and	return	the	reply-slip	below,	indicating	each	period	in	which	you	are	prepared	to	accept	student	
attachments	in	your	practice.
I	would	be	pleased	 to	answer	any	queries	you	may	have	 regarding	 this	attachment	programme.	No	previous	
experience	is	necessary	-	interest	and	motivation	to	teach	and	pass	on	your	expertise	are	much	more	important.
	 	 	 	 	 	 	 Prof.	Cindy	L.K.	Lam
	 	 	 	 	 	 	 Head,	Department	of	Family	Medicine	
	 	 	 	 	 	 	 					and	Primary	Care
	 	 	 	 	 	 	 The	University	of	Hong	Kong		
_____________________________________________________________________________________
REPLY SLIP
To			:			Prof.	Cindy	L.K.	Lam
I	will	be	willing	to	take	a	student	for	attachment	in	my	practice	during	the	following	teaching	blocks	(please	tick	as	
appropriate):-
	 	 October	15,	2012	–	December	15,	2012	 	 February	18,	2013	–	April	20,	2013	
	 	 December	17,	2012	–	February	16,	2013	 	 	 	
Name	 :		___________________________________________________(_________________________)
			 	 in	English		(block	letter)	 in	Chinese
Office	Address	 :		_____________________________________________________________________________
	 	 _____________________________________________________________________________
Office	Tel.	No.	 :		________________________________	 Fax.	No.		:		________________________________
	 	 ________________________________	 	 _______________________________
	 Signature	 Date
Please	return	the	completed	form	with	a	copy	of	your	curriculum	vitae	to:	
Prof.	Cindy	L.K.	Lam,	Department	of	Family	Medicine	and	Primary	Care,	University	of	Hong	Kong,	3/F.,	Ap	Lei	
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A pi lot study on cl inical outcomes of a 
‘repeat prescription’ programme
Tammy	KW	Tam	譚嘉渭，KH	Kwok	郭冠雄，Luke	CY	Tsang	曾昭義
Summary
Objective: To study changes in clinical parameters 
and pattern of health seeking behavior of patients 
after joining the ‘repeat prescription’ programme. To 
report on rate of adverse events and patient’s level of 
satisfaction.
Design: Retrospective cohort.
Subjects: Patients who joined the repeat prescription 
programme in a primary care clinic from May 2004 to 
February 2008.
Main outcome measures: Mean blood pressure and 
lipid level, number of diagnostic codes per consultation, 
number of breakthrough consultations. Rate of adverse 
events. Level of satisfaction. 
Results: By the end of the study period, 210 subjects 
who have been in the programme for ≥ 1 year were 
included for outcome analysis. Significant reductions 
in mean systolic blood pressure of 2.2 mmHg (p=0.01) 
and diastolic blood pressure of 2.2 mmHg (p=0.0003) 
were observed; there were no significant changes in 
lipid levels (p=0.30). Significantly more diagnostic codes 
were entered per consultation (p=0.0003). No adverse 
event was reported. 99% of patients were satisfied or 
highly satisfied with the programme.
Conclusion: This pi lot study shows that a repeat 
prescription arrangement is worthy of development 
in the context of pr imary care. Further studies in 
larger scale, longer duration, more clinical conditions, 
involving cost effectiveness considerations might be 
beneficial for the increasingly overloaded public primary 
health care sector.
Keywords: Repeat prescription, chronic illness, clinical 
outcome
摘要
目的：研究參加重複處方項目的患者臨床指標及求醫行為
模式的變化，並報告其不良事件率和患者滿意度。
設計：回顧性隊列研究。
對象：2004年5月至2008年2月間，某基層醫療診所參加重
複處方項目的患者。
主要測量內容：血壓和血脂平均值、每次就診的診斷編碼
數量、未預約就診的次數、不良事件率和滿意度。 
結果：截至研究結束，共有210位加入時間已達到或超過1
年，被吸納做臨床結果分析。血壓下降有顯著意義，收縮
壓平均值下降2.2	mmHg (p=0.01)，舒張壓下降2.2	mmHg	
(p=0.0003)；血脂水平無顯著變化 (p=0.30)；每次就診的診
斷編碼數量有所增加 (p=0.0003)。無不良事件報告；99%的
患者對此項目感到滿意或十分滿意。
結論：臨床效果預備研究顯示，重復處方項目在基層醫學
領域有發展價值，進行更大規模、更長時間、包含更多臨
床疾病和成本效益的綜合研究 ，可能對於日漸超負荷運作
的公共醫療服務有所幫助。
主要詞彙：重複處方，慢性疾病，臨床結果
HK Pract  2012;34:57-63
Introduction
	 For	 most	 patients	 with	 stable	 chronic	 medical	
c o nd i t i o n s , 	 t h e i r 	 r i t u a l i s t i c 	 r e t u r n	 t o 	 med i c a l	
consultations	 involves	mainly	 confirmation	 of	 their	
stable	 clinical	 status	 and	 re-stocking	 of	 necessary	
medications.	This	 ebb	 and	 flow	 of	 patients	 utilizes	 a	
significant	 amount	 of	 healthcare	 resources.	 ‘Repeat	
prescription’	 refers	 to	 the	 issuing	 of	 a	 subsequent	
prescr ip t ion	 wi thin	 a	 g iven	 per iod,	 whether	 i t	 i s	
accompanied	 by	 a	 doctor ’s	 consul ta t ion	 or	 not . 1	
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This	 practice	 has	 been	widespread	 in	 health	 care	 for	
some	 t ime.	 In	Western	 countr ies ,	 the	 proport ions	
of	 repeat	 prescript ion	 range	 from	 29%	 to	 75%	 of	
all	 i tems	 prescribed,2-3	 a	 substantial	 part	 of	 which	
involves	medications	 that	 are	 potentially	 toxic	 such	 as	
psychotropics,	 cardiac	 drugs	 and	 anti-epileptic	 drugs,	
and	 are	 issued	without	 direct	 doctor-patient	 contact.4-5	
There	 is	 also	 a	wide	 variation	 in	 reviewing	 policies	
between	 practices;	 a	 clinical	 review	 published	 by	De	
Smet	&	Dautzenberg	 in	 2004	demonstrated	 that	 66%	of	
repeat	 prescriptions	were	 not	 periodically	 reviewed	 in	
the	previous	2	years.1	 	
	 The	potential	benefits	of	repeat	prescription	without	
a	doctor’s	 consultation	are	 reduced	costs	 for	 the	 service	
provider,	 expanded	 servicing	 capacity	 of	 the	 healthcare	
system	 and	 increased	 convenience	 for	 the	 patient.1	 On	
the	other	hand,	 traditional	models	of	 repeat	 prescription	
have	 been	 criticized	 on	 its	 compromised	 quality	 on	
patient	care	and	 failure	 to	monitor	 the	effectiveness	and	
safety	 of	 the	 prescribed	medication	 regime.1	No	 doubt,	
repeat	 prescribing	 in	 the	 absence	 of	 patient	 contact	
should	never	be	undertaken	as	a	light	matter.
	 	
	 To	 address	 the	 drawbacks	 of	 repeat	 prescription,	
studies	 have	 been	 conducted,	 targeting	 at	 developing	
interventions	 to	 improve	 the	 quality	 and	 process	 of	
repeat	 prescriptions.6-9	 Nonetheless,	 published	 studies	
have	 yet	 to	 evaluate	 repeat	 prescription	 objectively	 in	
terms	 of	 its	 humanistic,	 economic	 or	 clinical	 outcomes	
to	guide	future	approach	in	its	utilization.
	
	 A	 controlled	 programme	 of	 repeat	 prescription	
was	 piloted	 in	 a	 primary	 care	 clinic	 in	May	2004,	with	
an	 aim	 to	 improve	 the	 organization	 and	monitoring	
of	 the	 process	 of	 repeat	 prescription,	 and	 hoping	 to	
achieve	 an	 optimal	 balance	 between	 increasing	 the	
clinic’s	 servicing	 capacity	 and	 yet	 upholding	 drug	
safety	 and	 good	 standard	 of	 patient	 care.	 The	 pilot	
stage	 of	 this	 programme	 recruited	 only	 patients	with	
stable	 chronic	 diseases.	At	 the	 end	 of	 2008,	 the	 clinic	
had	 around	 44,000	 patients	 in	 its	 registry.	 For	 the	
clinic,	 all	medical	 appointments	were	 normally	made	
by	 telephone	 booking	 up	 to	 1	 week	 in	 advance	 of	
the	 requested	 day	 of	 appointment.	 For	 patients	with	
chronic	 illnesses/conditions	 like	 hypertension,	 diabetes	
mellitus,	 etc.,	 at	 each	 attendance,	 they	would	 be	 given	
a	 follow-up	 appointment	 to	 enable	 continued	 care	 and	
monitoring	 by	 the	 attending	 physician.	 Usually,	 the	
follow-up	 interval	 would	 be	 12	weeks	 and	 at	most	 16	
weeks,	 which	 is	 also	 the	maximum	 duration	 of	 drug	
dispensed.
	
	 We	 hope	 that	 the	 results	 generated	 from	 the	 pilot	
repeat	 prescription	 programme	would	 provide	more	
insight	 to	 development	 of	 future	 repeat	 prescription	
model	 in	 primary	 care	 setting,	 and	 help	 to	 improve	
safety	of	patients	on	repeat	prescription.	
Method
	 Our	 s tudy	 was	 conducted	 in	 a	 publ ic	 funded	
primary	care	clinic	in	Hong	Kong.
	
	 After	 identifying	 appropriate	 patients,	 clinical	
parameters	 of	 pat ients	 before	 and	 af ter	 u t i l iz ing	
the	 repeat	 prescription	 system	were	 compared,	 and	
evaluated	 to	 check	 if	 the	 process	 of	 repeat	 prescription	
would	 affect	 disease	 control	 adversely	 or	modify	 the	
patient’s	 health	 seeking	 behavior.	Adverse	 events	were	
carefully	monitored.	 Patients’	 satisfaction	 to	 the	 change	
was	also	collected.	
The Repeat Prescription (RP) Programme
	 From	May	 2004	 through	 February	 2008,	 patients	
with	 stable	 chronic	 condition	were	 invited	 to	 join	 the	
RP	 programme.	 Under	 usual	 care,	 a	 patient	 would	
be	 arranged	 to	 see	 the	 physician	 every	 12	weeks	 for	
follow-up.	Under	 the	RP	 programme	 patients	would	 be	
followed	 up	 at	 a	 longer	 interval	 -	 24	weekly	 instead	 of	
12	weekly.	If	conditions	allowed,	they	would	be	stocked	
with	 12	weeks	medications	 after	 each	 consultation,	 and	
between	 the	 two	 consultations,	 a	 specially	 trained	 and	
experienced	 nursing	 colleague	will	 be	 responsible	 to	
check	 their	 condition,	 check	 their	 level	 of	 satisfaction	
and	 arrange	 re-stocking	 of	 the	medications	 for	 another	
12	weeks.	
	 The	 ch ron i c	 cond i t i on s	 i n c l uded	 i n	 t h e	 RP	
programme	 were	 hypertension,	 diabetes	 mell i tus,	
hyperlipidaemia,	 gout,	 asthma,	 allergic	 rhinitis,	 benign	
prostatic	 hyperplasia,	 dry	 eyes	 and	 onychomycosis.	The	
inclusion	 criteria	were	 a	number	of	 clinical	 assessments	
that	 indicated	 that	 the	 chronic	 condition	was	 stable.	
(Appendix I)	The	 criteria	were	 decided	 by	 the	Clinical	
Practice	 Improvement	Team	 of	 our	 unit	 after	 several	
team	meetings	 with	 physicians,	 nursing	 colleagues,	
dispensing	colleagues,	and	clerical	colleagues.
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	 During	 the	 study	 period,	 chronic	 patients	 attending	
follow-up	 consultation	 were	 screened	 by	 their	 case	
physician	 for	 el igibil i ty	 for	 inclusion	 into	 the	 RP	
programme.	 Patients	 attending	with	 any	 of	 the	 listed	
conditions	 and	 had	 fulfilled	 the	 specified	 inclusion	
criteria	would	 be	 personally	 invited	 to	 participate	 in	
the	 RP	 programme	 on	 a	 voluntary	 basis.	 Should	 any	
problem	related	 to	 their	 illnesses	arise	 in	 the	RP	period,	
for	 example	 deteriorated	 disease	 control,	 unscheduled	
consultations	 would	 be	 made	 for	 them	 to	 see	 their	
case	 physician	 as	 soon	 as	 possible;	 who	would	 then	
determine	whether	 or	 not	 these	 patients	would	 continue	
to	be	included	in	the	RP	programme.	
	 After	 starting	 the	 RP	 programme	 each	 subject	
would	 be	 given	 an	 identification	 number	 for	 quick	
retrieval	 of	 details	 including	 name,	Hong	Kong	 identity	
number,	 type	 of	 clinical	 conditions	 and	 name	 and	
duration	 of	medications	 to	 be	 re-stocked.	 Individual	
chart	review	was	performed	to	obtain	clinical	data.
	 To	 evaluate	 the	 cl inical	 outcomes	 of	 subjects	
before	 and	 after	 starting	 the	 RP	 programme,	 those	
who	 had	 been	 on	 the	 programme	 for	 one	 year	 or	more	
were	 included	 for	 data	 analysis,	 and	 specific	 clinical	
parameters	were	 used	 for	 comparison.	 For	 instance,	 for	
hypertension,	 the	mean	 recorded	 clinic	 blood	 pressure	
over	 the	 past	 year,	 before	 the	 change	 and	 then	 over	 the	
ensuing	 year	 before	 the	 last	 day	 of	 consultation	were	
compared.	 Similarly,	 for	 diabetes	mellitus,	 asthma,	
gout,	 and	 hyperlipidaemia,	 the	mean	 values	 of	 glycated	
haemoglobin,	 peak	 flow	 rate,	 number	 of	 gouty	 attacks,	
and	 the	 ratio	 of	 total	 cholesterol	 (TC)	 to	 high	 density	
level	 cholesterol	 (HDLC)	 respectively	were	 compared.	
To	 evaluate	 whether	 the	 health	 seeking	 behavior	 of	
subjects	had	been	modified	after	 joining	 the	programme,	
the	 frequency	 of	 subject	 attending	 the	 clinic	was	 also	
monitored	i.e.	more	unscheduled	consultations,	either	for	
concerns	 about	 the	 identified	 conditions	 or	 other	 acute	
problems;	and	whether	subjects	would	present	with	more	
complaints	 during	 subsequent	 follow-up	 consultations,	
reflected	in	increased	diagnostic	codes	per	consultation.
	
	 The	 level	 of	 satisfaction	with	 the	RP	 programme	
and	the	rate	of	adverse	events	were	also	recorded.	 	 	
Statistical	analysis
	 The	results	were	expressed	as	proportions,	means,	
and	 standard	 errors	where	 appropriate.	 Student	 t	 test	
was	 performed	 to	 compare	 continuous	 variables	 and	
Pearson	chi-square	test	to	compare	categorical	variables.	
A	 two-sided	 p	 value	 of	 <	 0.05	was	 used	 to	 indicate	
statistical	 significance.	All	 statistical	 analyses	were	
performed	with	the	use	of	SAS	software,	version	9.1.	
	
Results
	 Dur ing	 the	 s tudy	 pe r iod ,	 304	 pa t i en t s	 were	
recruited	 to	 the	 RP	 programme.	Table 1	 showed	 the	
characteristics	 of	 subjects.	 Over	 eighty	 percent	 of	
subjects	 (255)	 had	 one	 chronic	 illness,	 the	 commonest	
condition	 being	 hypertension	 (Table 2);	 90%	 (276)	
required	 less	 than	 three	 types	 of	medications	 for	 drug	
restock.
	
	 O f 	 t h e 	 3 0 4 	 s u b j e c t s , 	 2 1 0 	 h a d 	 b e e n 	 i n 	 t h e	
programme	 for	 one	 year	 or	more.	Analysis	 of	 specific	
clinical	parameters	showed	that	the	mean	blood	pressure	
of	 the	 RP	 group	was	 127.5/77.4	mmHg;	 there	was	 a	
small	 but	 statistically	 significant	 reduction	 of	 2	mmHg	
in	mean	 systolic	 (p=0.01)	 and	 diastolic	 blood	 pressure	
(p=0.0003)	 after	 joining	 the	 programme;	 and	 there	was	
an	 insignificant	 increase	 in	 the	 ratio	 of	 total	 cholesterol	
over	 high	 density	 level	 cholesterol	 (TC/HDLC).	 For	
other	 types	 of	 chronic	 illnesses,	 the	 number	 of	 subjects	
was	 not	 adequate	 for	 a	 valid	 comparison.	There	was	
no	 significant	 difference	 in	 the	 number	 of	 unscheduled	
consultations,	 either	 for	 identified	RP	 condition	 or	 non	
RP	 condition,	 but	 the	 number	 of	 diagnostic	 codes	 per	
consultation	 increased	 after	 entering	 the	 programme	
(p=0.0003).	(Table 3)
Table 1: Subject characteristics (N=304) 
Gender	
Male	 	 	 161	(53.0%)
Female		 	 143	(47.0%)
Mean age (years)	 	 58.4	±	8.3
Mean body mass index kg/m2	 24.3	±	3.6
Mean duration of illness (years)	 9.0	±	5.0		
	 	 	 (1.7	–	33.0	)
Mean duration of repeat prescription (years)	 1.7	±	1.0	
	 	 	 (1.2	-	52.8	months)
Number of drug items for repeat prescription	
	 	 1	 197	(64.8%)
	 	 2	 79	(26.0%)
	 	 3	 22	(7.2%)
	 	 4	 5	(1.6%)
	 	 5	 1	(0.3%)
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	 D u r i n g 	 t h e 	 s t u d y 	 p e r i o d , 	 m o n i t o r i n g 	 o f	
subject’s	 level	 of	 satisfaction	was	 conducted	 by	nursing	
colleagues	 during	 the	 interim	 patient	 review.	 This	
showed	 that	 99%	 of	 subjects	were	 satisfied	 or	 highly	
satisfied	with	 the	 programme.	No	 adverse	 events	were	
reported.	
	 The	 d rop -ou t	 r a t e	 f rom	 the	 p rog ramme	 was	
6 . 1% . 	 T h e 	 r e a s o n s 	 f o r 	 d r o p p i n g 	 o u t 	 i n c l u d e d	
patient’s	 preference,	 unsatisfactory	 disease	 control,	
non-compliance	with	medications,	 side	 effects	 of	 drugs,	
and	ineligibility	for	joining	the	RP	programme.
Discussion
	 Results	 of	 our	 study	 revealed	 that	 after	 entering	
the	 programme,	 blood	 pressure	 levels	 significantly	
decreased	 by	 around	 2mmHg.	Although	 this	may	 not	
be	 clinically	 significant,	more	 importantly,	 by	 the	 end	
of	 the	 study	 period	 of	 almost	 4	 years,	 these	 clinical	
parameters	 had	 remained	 rather	 optimal	 with	mean	
SBP	measured	 120-130	mmHg,	mean	DBP	measured	
70-80	mmHg.	These	 initial	 results	were	 encouraging.	
The	 selection	 criteria	 established	 by	 our	 team	 played	 a	
crucial	 role	 in	maintaining	 a	 good	 standard	 of	 care	 for	
selected	 patients	 on	RP.	The	 selection	 criteria	 enabled	
case	 physicians	 to	 detect	 any	 disease	 progression	 early	
enough	 and	 to	 act	 promptly,	 by	 diverting	 patients	 back	
to	 the	 usual	 care	 schedule,	 and	 had	 their	 condition	
optimized	before	re-entering	the	RP	programme	again.
	
	 We	also	found	that	RP	under	the	current	programme	
had	 not	 changed	 patient’s	 health	 seeking	 behavior	
to	 a	 great	 degree.	Although	 there	 was	 a	 small	 but	
statistically	 significant	 increase	 in	 the	 number	 of	minor	
physical complaints in subsequent consultations (↑0.18 
diagnostic	 code/consultation),	 this	 small	 numerical	
difference	may	 not	 be	 clinically	meaningful.	And	 it	
was	 a	 relief	 to	 observe	 that,	 there	was	 no	 increase	 in	
total	 number	 of	 unscheduled	 consultations.	 Participants	
seemed	 not	 to	 have	 become	 excessively	worried	 about	
their	health	status	or	other	health	problems	after	 joining	
the	 RP	 programme.	 In	 fact ,	 most	 subjects	 showed	
high	 satisfaction	 to	 the	RP	 programme	 and	 only	 very	
few	 dropped	 out	 (6 .1%)	 during	 the	 s tudy	 per iod.	
As	 the	 most	 common	 condition	 for	 drug	 refill	 was	
hypertension,	 and	most	 subjects	 in	 this	 study	 had	 home	
BP	machine	 for	 self-monitoring,	 the	 home	 readings	
might	 have	 also	 helped	 to	 assure	 the	 participants	 that	
their	 condition	was	 stable.	Most	 importantly,	 the	 nurses	
who	were	available	 to	assess	 them	 in	 the	 interim	period	
probably	provided	much	needed	support	 that	had	helped	
Table 2:  Number of patients for different types of 
diseases 
Types of chronic conditions Number of patients
Hypertension	 198
Diabetes	mellitus	 4
Asthma	 2
Hyperlipidaemia	 58
Benign	prostatic	hyperplasia	 12
Gout	 10
Hypothyroidism	on	thyroxine	replacement	 40
Allergic	rhinitis	 12
Eczema	 10
Chronic	urticaria	 2
Onychomycosis	 1
Dry	eyes	 7
Others	 8
N.B. some patients have more than one chronic condition 
Table 3. Comparison of clinical variables before and after joining repeat prescription programme  
Clinical variable Before joining RP program After joining RP program Magnitude of difference (after-before) p value
No.	of	unscheduled	consultation	
(RP	conditions)	 0.07	 0.04	 -0.03	 0.4
No.	of	unscheduled	consultation	
(non	RP	conditions)	 0.5	 0.62	 0.12	 0.17
No.	of	diagnostic	codes/	consultation	 1.77	 1.95	 0.18	 0.0003*
Mean	systolic	blood	pressure	(mmHg)	 129.7	 127.5	 -2.2	 0.01*
Mean	diastolic	blood	pressure	(mmHg)	 79.6	 77.4	 -2.2	 0.0003*
Mean	ratio	of	total	cholesterol/high	density	
level	cholesterol	 4.3	 5.4	 1.1	 0.3
	 	 	 	
* statistically significant	 	 	 	
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to	 alleviate	 any	 anxiety.	 This	 idea	was	 very	 similar	
to	 nurse-led	 clinics	 which	 has	 become	 increasingly	
popular	 in	 the	 recent	 decade.	A	 randomized	 controlled	
trial	 involving	 dermatology	 practice	 has	 showed	 that	
nurses,	 by	 providing	 effective	 patient	 education	 and	
support,	 can	 help	 to	 free	 up	 physician's	 time,	 allowing	
physicians	 to	 see	more	 patients.10	 Potentially,	 the	RP	
programme	may	 lead	 to	 improved	 cost	 effectiveness	 of	
the	healthcare	system	by	enhancing	the	role	of	nurses	in	
patient	management.
	 Furthermore,	 during	 the	 study	 period,	we	 observed	
low	 rate	 of	 patient	 non-compliance	 to	 medications	
(1.2%)	 and	 no	 adverse	 event	 arose	 that	was	 related	 to	
the	RP	 programme.	All	 subjects	 in	 the	RP	 programme	
were	 given	 a	 hotline	 telephone	 number	 through	which	
they	 could	 talk	with	 the	 nurses	 directly	 during	 office	
hours	whenever	 they	 encountered	 problems	with	 the	
use	 of	medications.	The	high	 rate	 of	 compliance	was	 in	
contrast	with	 other	 studies,	which	 reported	 that	 12.4%	
of	 patients	 had	 compliance	 problems,	 side-effects,	
adverse	drug	reactions,	or	drug	interactions.11	
Limitations
	 However,	 at	 this	 point,	 the	 available	 evidence	 is	
not	 sufficiently	 strong	 for	 us	 to	 conclude	 that	RP	 under	
the	monitored	programme	would	have	no	 adverse	 effect	
on	 the	 long	 term	 clinical	 outcomes	 such	 as	 disease	
complications	 and	mortality	 as	 compared	with	 usual	
care.	 Obviously,	 more	 clinical	 data	 are	 needed	 and	
further	 controlled	 trials	with	 parallel	 comparison	 of	 the	
control	(usual	care	system)	and	intervention	(RP	system)	
groups	are	 required	 to	provide	a	stronger	conclusion	 for	
this	question.	 	
	 Compared	with	 the	 traditional	 system	 of	 repeat	
prescription,	 where	 a	 wide	 variety	 of	 medications	
including	 antibiotics,	 psychotropics,	 anti-epileptics	
and	 cardiovascular	 drugs	 would	 be	 refilled	 without	
consultation	 and	 for	 even	 longer	 periods,	 the	 scale	 of	
repeats	 in	our	programme	was	much	smaller.	One	might	
challenge	 that	 the	 impact	 of	 our	 repeat	 system	 on	 the	
overall	 healthcare	 capacity	would	 be	 small.	 However,	
this	 was	 only	 the	 pilot	 stage	 of	 our	 programme.	 In	
the	 era	 of	 an	 aging	 population,	 and	 substantial	 rise	 in	
the	 prevalence	 of	 chronic	 illnesses,	 the	 scale	 of	 the	
RP	 programme	would	 also	 expand	 accordingly.	We	
might	 also	 consider	 extending	 the	 period	 of	 repeat,	 and	
simplifying	 and	 streamlining	 the	 repeat	 procedure	 to	
promote	 a	 higher	 rate	 of	 participation	 of	 both	 doctors	
and	 patients.	Most	 importantly,	 the	 clinical	 outcomes	
of	 patients	 should	 be	 reviewed	 regularly.	 By	 following	
the	 stringent	 selection	criteria,	our	programme	will	help	
to	maintain	 a	 standard	 quality	 of	 drug	 use	 and	 patient	
care,	which	will	 in	turn	contribute	to	a	good	standard	of	
chronic	care	modeling.
	
	 To	 the	best	of	our	knowledge,	 this	study	 is	 the	first	
of	 its	 kind	 to	 objectively	 evaluate	 clinical	 outcomes	
after	 repeat	 prescription.	At	 this	 pilot	 stage,	 the	 sample	
size	 was	 relatively	 small	 compared	 with	 the	 whole	
clinic	 population.	 Time	 constraint	 in	 a	 busy	 clinic	
setting	 and	 the	 extra	work	 involved	 had	 been	 the	major	
barriers	 for	 doctors	 to	 do	 the	 invitations	 to	 include	
patients	 to	 the	RP	 programme.	With	 the	 present	 sample	
size,	we	were	only	able	to	assess	the	blood	pressure	and	
serum	 lipid	 levels,	while	 comparative	 analysis	 for	 other	
diseases	was	 not	 performed.	 But	with	 the	 encouraging	
results	 obtained	 in	 this	 first	 phase	 of	 programme,	we	
believe	 that	 comprehensive	 evaluation	 of	 the	whole	
spectrum	 of	 chronic	 diseases	would	 be	 possible	with	
further	recruitment	of	patients	in	the	near	future.
	
	 This	 is	 a	 retrospective	 study	 to	 review	 clinical	
outcomes	 of	 RP	 patients	 by	 the	 fourth	 year	 of	 the	
programme.	Duration	 of	 chronic	 illness	may	 also	 affect	
disease	 progression,	 and	 may	 become	 confounders	
to	 our	 results.	 Standardization	 of	 patient’s	 duration	
of	 illness,	 or	 conducting	 clinical	 trials	 to	 compare	
outcomes	 between	 RP	 group	 and	 usual	 care	 group	
would	help	to	reduce	the	biases	involved.
	
	 A s 	 r e p e a t 	 p r e s c r i p t i o n 	 u s e d 	 i n 	 l o n g - t e rm	
pharmacotherapy	 is	 often	 associated	with	 patient	 non-
adherence,12	 under	 our	 current	 system,	we	were	 only	
able	to	monitor	drug	compliance	for	patients	who	turned	
up	for	follow-up,	and	not	for	 those	who	defaulted	in	 the	
interim	 period.	The	 overall	 rate	 of	 drug	 non-adherence	
and	 its	 ultimate	 effect	 on	 disease	 outcomes	might	 be	
under-estimated.	 Establishment	 of	 a	 call-back	 system	
might	 be	 considered	 to	 help	 identify	 defaulters	 in	 the	
interim	period	and	arrange	them	for	further	follow-up.	
Conclusions
	 Af ter	 implementa t ion	 of	 the	 RP	 programme,	
control	 of	 hypertension	 and	 hyperlipidaemia	 remained	
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stable.	No	 adverse	 events	were	 reported	 and	 patients’	
satisfaction	levels	were	high	in	this	cohort.	The	essential	
elements	 of	 success	 for	 this	 pilot	 programme	 included	
careful	 selection	 of	 patients	 against	 the	 specified	 list	 of	
inclusion	criteria	and	having	a	 team	of	dedicated	nurses	
to	 provide	 the	 needed	 support	 in	 patient	 review	 and	
use	 of	medications.	Hopefully,	 our	 study	 has	 painted	
a	 primitive	 framework	 for	 future	 development	 of	 the	
repeat	 prescription	 arrangement,	 to	maximize	 patient	
coverage	while	balancing	 the	quality	of	patient	care	and	
medication	safety.	
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Appendix I
Inclusion criteria for “Repeat Prescription Programme”
Clinical	condition	 	 Inclusion	criteria
Hypertension	 	 –	 Uncomplicated	hypertension	without	target	organ	involvement
	 	 	 –	 Consecutive	clinic	BP	<140/90	for	2	times	or	more
	 	 	 –	 Repeat	drug(s)	for	12	weeks
	 	 	 –	 Review	24/52
Diabetes	mellitus	 	 –	 Uncomplicated	DM
   – Optimal glycemic control with HbA1c ≤ 7.0%
	 	 	 –	 Repeat	drug(s)	for	12	weeks
	 	 	 –	 Review	24/52
	 	 	 For	 those	 patients	who	 have	 both	DM	 and	HT,	 they	 are	 also	 eligible	 provided	
that	both	selection	criteria	were	satisfied
Asthma	 	 –	 Free	of	asthmatic	attacks	for	at	 least	6	months
	 	 	 –	 Repeat	drug(s)	for	12	weeks
	 	 	 –	 Review	24/52
Gout	 	 –	 Free	of	gouty	attacks	for	at	 least	6	months
	 	 	 –	 Repeat	drug(s)	for	12	weeks
	 	 	 –	 Review	24/52
Hyperlipidaemia	 	 –	 Optimal	lipid	profile
	 	 	 –	 Repeat	drug(s)	for	12	weeks
	 	 	 –	 Review	24/52
Hypothyroidism	on	T4	replacement	 	 –	 Normal	thyroid	function	test	for	2	or	more	consecutive	years
	 	 	 –	 Repeat	drug(s)	for	16	weeks
	 	 	 –	 Review	32/52
Allergic	rhinitis	 	 –	 No	previous	complications	e.g.	sinusitis,	middle	ear	effusion
	 	 	 –	 Stable	symptom	control
	 	 	 –	 Repeat	drug(s)	(can	include	nasal	steroid)	for	12	weeks	each	time
	 	 	 –	 Review	yearly
Eczema	 	 –	 Stable	symptom	control,	mild	to	moderate	eczema
	 	 	 –	 Do	not	repeat	very	potent	 topical	steroid	(Dermovate)
	 	 	 –	 Repeat	other	drug(s)	for	12	weeks
	 	 	 –	 Review	24/52
Chronic	urticaria	 	 –	 Stable	symptom	control	
	 	 	 –	 Repeat	drug(s)	for	12	weeks	each	time
	 	 	 –	 Review	yearly
Benign	prostatic	hyperplasia	 	 –	 Stable	symptom	control	for	at	 least	6	months
	 	 	 	 –	 Normal	renal	function	and	PSA		
	 	 	 	 –	 Repeat	drug(s)	for	12	weeks
	 	 	 	 –	 Review	24/52	
Onychomycosis	on	systemic	anti-fungal	agents	 	 –	 Satisfactory	treatment	progress
	 	 	 	 –	 Normal	liver	function
	 	 	 	 –	 Repeat	drug(s)	for	12	weeks	
	 	 	 	 –	 Review	24/52
Dry	eyes	 	 	 –	 Clinical	 diagnosis	 documented	 by	 ophthalmologists	 or	 doctors	 in	 families	
clinics
	 	 	 	 –	 Absence	of	coexisting	eye	disorders
	 	 	 	 –	 Repeat	eye	drops	for	12	weeks	(maximum	3	bottles)	
	 	 	 	 –	 Review	1	year
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An evidence-based clinical audit on smoking 
cessation management for patients with 
chronic diseases in a Hong Kong general 
outpatient clinic
L	Lo	盧令，David	VK	Chao	周偉強
Summary
Objective: To evaluate smoking cessation management 
for patients with chronic diseases in a Hong Kong 
public primary care clinic by conducting a clinical audit, 
with an aim to induce change and improvement in 
service provision.
Design: The f i r s t phase o f the aud i t (7 /2007 to 
6/2008) was a retrospective medical record review 
that identif ied potential areas for enhancements in 
smoking cessation service. The second phase (7/2008 
to 6/2009) was a prospective audit period implementing 
the improvement changes. Results from the two phases 
were compared.
Subjects: Al l patients attending the Day, Evening, 
Sunday and Public Holiday clinics with one or more 
of the following six most common chronic diseases 
namely, hypertension (HT), diabetes mell i tus (DM), 
asthma, chronic obstructive pulmonary disease (COPD), 
ischaemic heart disease (IHD), or cerebral vascular 
accident (CVA). 
Main outcome measures :  The da ta f rom the 2 
audit phases were measured against 5 audit criteria 
(Ask, Advice, Assess, Assist , Arrange) to look for 
improvement across the 2 phases and whether the final 
results were able to meet pre-set standards. 
Results: Statistically significant improvements were 
observed in cr i ter ia 1 to 3. Only cr i ter ion 5 could 
achieve the pre-set standard of 100%. 
Conclusion: A cl inical audit with a targeted team 
approach to implement changes was capab le o f 
achieving signif icant improvements in the process 
of care for smoking cessat ion. However, systems 
l imitations and human factors did exist preventing 
clinical performance to achieve pre-set standards. 
Keywords: Smoking, smoking cessation, clinical audit, 
chronic disease, evidence-based health care
摘要
目的：在本港一所公立基層醫療診所進行臨床審計，評估對
慢性疾病患者所提供戒煙服務的質素，以進行改善措施。
設計：臨床審計分兩段為期一年的時間進行。第一階段
（7/2007至6/2008）是將醫療記錄作回顧性分析，以確定在
戒煙服務上的潛在改善空間。第二階段（7/2008至6/2009）
是進行改善措施並作前膽性審計。最後，分析及比較兩個
階段中的服務質素，以研究作進一步改善。
對象：在日診、夜診、星期日及公眾假期診所求診的六種
常見慢性疾病患者，包括所有高血壓、糖尿病、哮喘、慢
性阻塞性肺病、缺血性心臟病及中風的病人。
主要測量內容：衡量在兩個階段數據中的五項審計準則：
詢問、建議、評估、協助、安排，以便確定質素是否得到
改善，並評估最終成果能否達到預定標準。
結果：戒煙服務中的首三項審計準則有顯著改善，而第四
及第五項審計準則因牽涉及人數較少，其改善程度未能確
定。於五項審計準則中，只有第五項能夠達到預定的 100% 
標準。在是次為期一年的臨床審計，4位病人能夠成功戒
煙，41位病人獲轉介至戒煙中心跟進。
結論：在指定團隊以臨床審計方法推行改善措施，能顯著
改善戒煙服務質素。然而，制度上的限制及人為因素的存
在，都阻礙了達至臨床上的預期標準。
主要詞彙：吸煙、戒煙、臨床審計、慢性疾病、實證醫學
醫療。
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Background
	 Smoking	 is	 arguably	 the	 most	 preventable	 cause	
of	 deaths	 in	 Hong	 Kong	 (HK)	 and	 in	 many	 other	
countries.	 Indeed,	 tobacco	use	 is	a	 risk	 factor	 for	6	of	
the	 8	 leading	 causes	 of	 deaths	 globally.1	 The	World	
Health	 Organizat ion	 est imates	 that	 smoking	 ki l ls	
nearly	 6	 million	 people	 a	 year,	 and	 approximately	
1 	 p e r s on	 d i e s 	 e v e r y	 6	 s e cond s	 du e	 t o 	 t o b a c co	
accounting	 for	 1	 in	 10	 adult	 deaths.	 Up	 to	 half	 of	 all	
current	 users	 will	 eventually	 die	 of	 a	 tobacco-related	
disease.
	 As	 at	 2010-2011,	 the	 prevalence	 of	 smoking	 in	
HK	 is	 approximately	 12.0	 -	 13.6%.	 Smokers	 consume	
an	 average	 of	 13.4	 cigarettes	 per	 day.	Of	 the	 smokers,	
68.8%	 are	 aware	 of	 local	 smoking	 cessation	 services	
but	only	2.5%	have	tried	them	before.2-3
	
	 A	 local	 s tudy4	 in	 2006	 es t imated	 that	 among	
those,	 in	 1998	who	were	 aged	 >35	 years,	 5,596	 and	
1,324	 deaths	 were	 attributed	 to	 active	 and	 passive	
smoking	 respectively.	 In	 2000,	 almost	 34,500	 people	
were	 hospitalized	 from	 smoking	 related	 i l lnesses.	
For	 adults,	 the	 attributable	 cost	 of	 public	 hospital	
use	 was	 $230	 mil l ion	 a	 year,	 represent ing	 7%	 of	
the	Hospital	Authority's	 total	 expenditure	 on	 public	
hospitals	 in	 1998.	The	 cost	 of	 visits	 to	 public	 primary	
care	 outpatient	 clinics	was	 estimated	 at	 $21	million,	
representing	 12%	 of	 the	 total	 cost	 for	 such	 clinics	 in	
1998.
	 Smoking	 poses	 a	 s ign i f i can t	 r i sk	 on	 hea l th ,	
regardless	 of	 age	 and	 sex.	 However	 patients	 with	
chronic	 diseases	 are	 especially	 at	 risk.	 The	General	
Outpatient	 Clinics	 (GOPCs)	 of	HK	 look	 after	 a	 large	
number	 of	 patients	with	 chronic	 diseases,	 and	 are	 also	
the	 point	 of	 entry	 for	 many	 other	 walk-in	 patients.	
GOPCs	 are	 therefore	 at	 a	 pivotal	 position	 to	 intervene	
and	to	offer	help	to	smokers.
	
	 The	 principal	 investigator	 conducted	 a	 clinical	
audit	 on	 smoking	 cessation	 because	 the	 standard	 of	
care	 in	 his	 clinic	 had	 room	 for	 improvement:	 the	 lack	
of	 standardized	 guidance	 for	 clinicians	 on	 smoking	
cessation	 practice,	 the	 relative	 lack	 of	 nursing	 and	
clerical	 support,	 and	 an	 apparent	 low	 intervention	 (e.g.	
referral	 /	 anti-smoking	 prescription)	 rate	 observed.	This	
situation	 is	 similar	 to	 the	 published	 data	 from	 another	
local	primary	care	clinic.5
Objective
	 The	 objec t ive	 of	 the	 audi t	 i s	 to	 evaluate	 the	
process	 of	 care	 for	 smoking	 cessation	 intervention	 in	
the	principal	 investigator’s	clinic,	with	an	aim	to	 induce	
change	and	improvement	in	service	provision:
● Improving identification and documentation of 
smokers	in	consultation
● Enhancing assessment of smokers’ intention to quit 
and	the	identification	of	motivated	quitters
● Providing consolidated assistance to motivated 
smokers	 by	 pharmacological	 treatments,	 referral	
and	follow-up	reviews
● Arousing the awareness of all fellow colleagues in 
the	 same	department	on	 the	 importance	of	 smoking	
cessation	
Method
Study	design
	 This	 cl inical	 audit	 consists	 of	 2	 phases,	 with	
comparable	 setup	 and	 collection	 of	 statistical	 data.	The	
first	 phase	 (1/7/2007	 to	 30/6/2008)	 is	 a	 retrospective	
review	 of	 records,	 followed	 by	 the	 identification	 of	
areas	 for	 enhancements.	The	 second	 phase	 (1/7/2008	 to	
30/6/2009)	 is	 a	 prospective	 audit	 period	 implementing	
the	 improvement	measures.	After	 the	 second	 phase,	 a	
final	 analysis	 is	 performed	 to	 compare	 the	 performance	
in	 the	 2	 phases	 and	 to	 further	 investigate	 areas	 for	
future	improvement.	
	 Medical	 records	were	 reviewed	 to	 assess	whether	
details	 relating	 to	 the	 5	 audit	 criteria	were	 included	 in	
the	records	during	the	pervious	12	months.
1.	 ASK	 	For	all	patients,	has	 the	smoking	status	
been	documented	in	notes?
2.	 ADVISE	 	For	 smokers,	 have	 they	 been	 advised	
to	 quit	OR	 advised	 about	 the	 hazards	
of	smoking?
3.	 ASSESS	 	For	 smokers,	 has	 their	willingness	 to	
quit	been	assessed?
4.	 ASSIST	 	For	motivated	smokers,	have	they	been	
offered	 pharmacological	 treatment	
OR	 referred	 to	 a	 specialized	 smoking	
cessation	centre?
5.	 ARRANGE	 	For	motivated	smokers,	were	follow-up	
appointments	arranged?	
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The	evidence-based	audit	criteria	
	 A	 l i terature	 search	 in	 Pubmed,	 corresponding	
government	 authorities,	 academic	 colleges,	 and	 local	
institutions	 involved	 in	 smoking	 cessation	 services	
was	 undertaken	 to	 retrieve	 relevant	 clinical	 resources	
including	 previous	 audit	 reports,	 established	 clinical	
guidelines,	 and	 known	 standards	 of	 care.	A	 number	
of	clinical	guidelines	on	 smoking	cessation	have	been	
released	by	various	health	authorities	and	professional	
organizat ions	 (Table 1) . 6-13	 However,	 there	 was	 a	
paucity	of	 local guidelines.
	 The	 5	 criteria	 used	 in	 this	 audit	 are	 based	 on	 the	
5A’s	 framework	 put	 forward	 by	 the	 US	 guideline.9	
The	 guideline	 was	 selected	 because	 it	 provides	 the	
most	 comprehensive	 information	 on	 the	 evidences	
underpinning	 i ts	 recommendations.	 The	 5	 cri teria	
a r e	 a l so	 we l l	 suppo r t ed	 by	 t he	 l a t e s t	 Coch rane	
reviews.14-18
	 Criterion	1	 (ASK).	This	 originates	 from	 the	 2000	
US	 Public	 Health	 Service	 clinical	 practice	 guideline:	
treating	 tobacco	 use	 and	 dependence.19	 The	 evidence	
supporting	 this	 stems	 back	 from	 the	 meta-analysis	 in	
the	 1996	 US	 Guideline,20	 where	 identifying	 smokers	
increases	 rates	 of	 clinician	 intervention.	Although	
a sk ing	 a l o n e 	 doe s	 no t	 improve	 ab s t i nence	 r a t e	
significantly,	 it	 forms	 the	 first	 step	 in	 providing	 any 
intervention	 to	potential	patients.	
	 C r i t e r i o n 	 2 	 (ADVICE ) . 	 Th e	 US	 Gu i d e l i n e	
recommends	 tha t	 a l l	 phys ic ians	 should	 s t rongly	
advise	 every	 smoker	 to	 quit	 because	 evidence	 shows	
tha t	 phys ic ian	 advice	 to	 qu i t	 smoking	 increases	
abst inence	 ra tes .	 The	 evidence	 or iginates	 f rom	 a	
meta-analysis	of	7	studies	 in	 the	1996	US	Guideline.20	
The	 benefit	 of	 physicians’	 advice	 is	 also	 supported	
by	 the	 latest	Cochrane	 review	 in	 2008,14	 showing	 that	
simple	 advice	 has	 a	 small effect	 on	 cessation	 rate.	
Assuming	 an	 unassisted	 quit	 rate	 of	 2	 to	 3%,	 a	 brief	
advice-intervention	 can	 increase	 quitting	 by	 a	 further	
1	 to	 3%.	 I t	 is	 also	 interest ing	 to	 note	 that	 advice	
delivered	 by	 other	 health	 care	 providers	 also	 result	
in	 an	 increased	 quit	 rates.21	 These	 support	 the	 team	
approach	 in	 intervening	patients	who	smoke.
	 C r i t e r i o n 	 3 	 (ASSESS ) . 	 T h e 	 US	 g u i d e l i n e	
recommends	 that	 once	 a	 tobacco	 user	 is	 identified	
and	 advised	 to	 quit,	 the	 clinician	 should	 assess	 the	
patient’s	 willingness	 to	 quit.	 One	 systematic	 review	
shows	 that	 assessing	 the	 smokers’	motivation	 enables	
a	stage-based	smoking	 intervention,	which	 is	effective	
in	changing	smoking	behaviour.22
	 Fo r	 t h e	 p r i n c i pa l 	 i nve s t i g a t o r ’s	 c l i n i c , 	 t h e	
availability	 of	 specialized	 smoking	 cessation	 service	
is	 limited.	Assessing	 the	 willingness	 to	 quit	 enables	
the	 clinician	 to	 stratify	 the	 more	 eager	 patients	 who	
would	benefit	most.	
	 Criterion	 4	 (ASSIST).	Assisting	 encompasses	 a	
range	 of	 cognitive	 and	 behavioural	 strategies	 offered	
by	 the	 clinician.	 Only	 prescriptions	 and	 referrals	 are	
audited	 in	 this	exercise.
	 The	 efficacy	 of	 the	 3	 first-line	 medications	 for	
smoking	 cessation	 (nicotine	 replacement	 therapy	 or	
NRT,	 Bupropion,	 and	Varenicline)	 is	 well	 evidenced	
by	 the	 Cochrane	 reviews,15-17	 the	 NICE	 review23	 and	
the	2008	US	Guideline.
	 T h e 	 U S 	 g u i d e l i n e 	 s h ow s 	 t h a t 	 c om b i n i n g	
medication	 and	 counseling	 is	 better	 than	 medication	
alone	 or	 counseling	 alone.	 Currently,	 combining	NRT	
prescription	and	 smoking	counseling	are	not	 a	 routine	
in	 GOPCs,	 but	 is	 part	 of	 the	 services	 provided	 in	
the	 specialized	 Smoking	 Counseling	 and	 Cessation	
Centres	 (SCCCs).
	 Cr i t e r ion	 5	 (ARRANGE) .	 The	 US	 gu ide l ine	
recommends	 that	 a l l	 smokers	 should	 be	 assessed	
with	 respect	 to	 their	 smoking	 status	 during	 follow-up	
c l i n i c a l 	 con t a c t s 	 o f 	 a l l 	 p a t i en t s . 	 I n	 p a r t i cu l a r,	
assessments	 wi th in	 the	 f i r s t	 week	 a f te r	 qu i t t ing	
should	 be	 encouraged.	 This	 recommendation	 is	 based	
on	 2	 studies.24-25	 However,	 the	 existing	 evidence	 does	
not	 show	 that	 these	 steps	 will	 prevent	 relapse,	 but	
continued	 involvement	 on	 the	 part	 of	 the	 clinician	
may	 increase	 the	 l ikel ihood	 that	 the	 pat ient	 wi l l	
consult	 the	clinician	 in	 later	quit	attempts	should	 they	
be	needed.	
Setting	of	 standards	
	 The	 sett ing	 of	 standard	 for	 each	 criterion	 has	
taken	 into	 consideration	 known	 standards	 published	
by	a	 local	audit5	 in	2005,	and	an	audit	protocol	by	 the	
National	 Institute	 for	 Health	 and	 Clinical	 Excellence	
(NICE)	of	 the	United	Kingdom	in	200626	 (Table 2).
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Table 1: Comparison of guidelines on smoking cessation
	 	 WHO6 UK-NICE7-8 US9 Australia-AFP10-12 New Zealand13
● Documentation of  √ √ √ √ √  
	 smoking status	 	 	 (evidence	A)	 (strength	A)	 (grade	A)
● Advice to quit OR  √ √ √ √ √
	 on smoking	 	 	 (evidence	A)	 (strength	A)	 (grade	A)
	 hazards	 	 	
● Assessment of √ √ √ √ X
	 willingness to quit	 	 	 (evidence	C)	 (strength	B)	
● Assessment of X (√) X √ √ 
	 nicotine 
	 dependence	
● Prescription of  √ √ √ √ √
	 NRT, Bupropion,	 	 	 	 (evidence	A)	 (strength	A)	 (grade	A)
	 or Varenicline	 	 	
● Referral to  X √ √ √ √
	 smoking cessation 	 	 	 (evidence	A)	 (strength	A)	 (grade	A)
	 centre OR 
	 telephone hotline	 	 	
● Assistance on √  X √ √ √
	 cognitive OR	
	 behavioural 
	 strategies	 	 	 	 	
● Arranging  √ √ √ √ √ 
	 follow-up for 	 	 	 (evidence	A)	 (strength	A)	 (grade	A)
	 review	
√ Recommended in guideline  (√) – Mentioned in guideline  X – Not mentioned in guideline
	
Levels	of	evidence	in	guidelines
US Guidelines –	Strength of Evidence
A.	 Multiple	well-designed	randomized	clinical	 trials,	directly	relevant	to	the	recommendation,	yielded	a	consistent	pattern	of	findings.
B.	 Some	 evidence	 from	 randomized	 clinical	 trials	 supported	 the	 recommendation,	 but	 the	 scientific	 support	was	 not	 optimal.	 For	
instance,	 few	 randomized	 trials	 existed,	 the	 trials	 that	 did	 exist	were	 somewhat	 inconsistent,	 or	 the	 trials	were	 not	 directly	 relevant	
to	the	recommendation.
C.	 Reserved	 for	 important	 clinical	 situations	 in	which	 the	Panel	 achieved	consensus	on	 the	 recommendation	 in	 the	 absence	of	 relevant	
randomized	controlled	trials.
Australian Guidelines - Strength of Recommendation
A.	 There	is	good	evidence	to	support	 the	recommendation
B.	 There	is	fair	evidence	to	support	 the	recommendation
C.	 There	 is	 poor	 evidence	 regarding	 the	 inclusion	 or	 exclusion	 of	 the	 recommendation	 but	 recommendations	may	 be	made	 on	 other	
grounds.
New Zealand Guideline - Grade of Recommendation
A.	 The	recommendation	is	supported	by	GOOD	(strong)	evidence.
B.	 The	recommendation	is	supported	by	FAIR	(reasonable)	evidence,	but	 there	may	be	minimal	inconsistency	or	uncertainty.
C. The recommendation is supported by EXPERT opinion (published) only.
I.	 There	is	INSUFFICIENT	evidence	to	make	a	recommendation.
P.	 GOOD	PRACTICE	POINT	(in	the	opinion	of	the	guideline	development	group).	
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Subjects 
	 The	 target	 population	 (grand	 audit	 population)	 in	
this	 audit	 is	 all	 patients	 attending	 the	 author’s	 clinic	
with	 any	 of	 the	 6	 commonest	 chronic	 diseases,	 namely	
hypertension	 (HT),	 diabetes	mellitus	 (DM),	 asthma,	
chronic	 obs t ruc t ive	 pu lmonary	 d isease	 (COPD),	
ischaemic	 heart	 disease	 (IHD),	 and	 cerebral	 vascular	
accident	 (CVA),	 and	who	 are	 at	 least	 seen	 once	 by	 one	
of	 the	 regular	 resident	 doctors	 in	 the	 clinic.	 Patients	
with	 the	specified	diagnoses	who	had	only	been	seen	by	
locum	 /	 relieving	 doctors	were	 excluded	 because	 of	 the	
potentially	wide	 variation	 in	 practice	 among	 this	 group	
of	doctors.
Sample	size	calculations
	 The	 grand	 target	 population	 has	 been	 defined	
above.	However,	 the	 “sub-population”,	 and	 therefore	
the	 sample	 size	 required,	 for	 each	 of	 the	 5	 criteria	 is	
different:
	 For	 criterion	 1	 (ASK),	 the	 population	 is	 the	 total	
number	 of	 eligible	 chronic	 patients.	 It	 is	 approximately	
18,000	 in	 each	 phase.	 From	 previous	 local	 audit	 data5	
and	 clinical	 experience,	 the	 percentage	 of	 smoking	
s tatus	 documentat ion	 is	 roughly	 90%.	 Therefore ,	
assuming	 that	 90%	 of	 the	 patients	 would	 meet	 the	
criterion,	 the	 sample	 size	 required	 at	 95%	 confidence	
leve l	 wi th	 95%	 conf idence	 in te rva l	 (85-95%)	 i s	
estimated	to	be	138.
	 For	 criteria	 2	 (ADVISE)	 and	 3	 (ASSESS),	 the	
populat ion	 is	 the total number of smokers.	 In	 the	
retrospective	 first	 phase,	 this	 number	was	 unknown	 as	
there	was	 not	 a	 complete	 list	 of	 smokers.	One	 solution	
was	 to	 retrieve	 and	 audit	 those	 patients	 coded27	with	
Tobacco	Abuse	 in	 the	clinic	computer	system.	However,	
there	 were	 only	 348	 such	 coded	 records.	 This	 low	
coding	 rate	meant	 that	 the	 coded	 list	 of	 smokers	was	
not	representative	of	the	total	number	of	smokers.	Many	
smokers	were	simply	un-coded.
	
	 In	 the	 second	 phase,	 the	 total	 number	 of	 smokers	
was	 again	 unknown.	 So,	 in	 order	 to	 find	 the	 total	
number	of	smokers,	 the	principal	investigator	underwent	
a	pilot	audit.
	
	 The Pilot and Main Audits.	 From	 the	 review	of	 the	
initial	 sample	 of	 138	 (above),	 it	 was	 found	 that	 there	
were	16	 smokers,	 120	non-smokers,	 and	2	patients	with	
unknown	 documentation	 status	 in	 the	 first	 phase.	The	
rough	 percentage	 of	 smokers	 in	 the	 clinic	was	 ~12%	
(=	 16/136).	Therefore	with	 the	 known	 grand	 population	
of	18,352	in	the	first	phase,	the	total	number	of	smokers	
was	roughly	2,159	(=	18,352	x	12%)	(Table 3).
	 In	 criteria	 2	 and	 3,	 the	 expected	 percentage	 of	
patients	 intervened	 (Advised	 or	Assessed)	 is	 uncertain.	
It	 is	 prudent	 to	 assume	 a	 50%	 chance	 to	 arrive	 at	 the	
largest	 possible	 sample	 size.	With	 a	 target	 population	
of	 ~2159,	 assuming	 that	 50%	 of	 the	 patients	 would	
meet	 the	 criterion,	 the	 sample	 size	 required	 at	 95%	
confidence	level	with	95%	confidence	interval	(45-55%)	
is	estimated	to	be	327.
	 As	 there	 was	 not	 a	 complete	 list	 of	 all	 smokers,	
those	 327	 smokers	 were	 extracted	 from	 the	 grand	
Table 2: Audit criteria and standards
	 	 Standard
Criteria	1
In	the	past	12	months,	has	the	smoking	status	of	all	patients	been	asked	and	documented	in	the	case	notes?	 100%
Criteria	2
In	the	past	12	months,	have	smokers	been	advised	to	quit	smoking	OR	the	hazards	of	smoking?	 100%
Criteria	3
In	the	past	12	months,	have	smokers	been	assessed	their	willingness	to	quit?	 100%
Criteria	4
In	the	past	12	months,	have	eager	smokers	been	assisted	by	offering	pharmacological	 treatment	OR	referral	 	 100%
to	a	specialized	smoking	cessation	service?	
Criteria	5
In	the	past	12	months,	have	eager	smokers	been	arranged	a	follow-up	appointment	for	review?	 100%
(Definition: Smokers means daily smokers; Ex-smokers means having quitted for > 4 months.)
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popu la t ion .	 Here	 2 ,780	 (=	 327	 /	 ~12%)	 random	
patients	 from	 the	 grand	 population	 were	 required.	
Allowing	a	10%	safety	margin,	3,058	 (2,780	x	110%	=	
3,058)	 records	 were	 ultimately	 reviewed	 to	 recruit	 the	
327	 smokers.	A	 similar	 pilot	 audit	was	 also	 performed	
for	 the	 second	 phase	 to	 f ind	 the	 to ta l	 number	 of	
smokers.
	 For	 criteria	 4	 and	 5,	 the	 population	 is	 theoretically	
the	 total	 number	 of	 smokers	 who	 are	 eager	 to	 quit.	
This	 figure	 is	 expected	 to	 be	 small.	And	 even	 smaller	
i s	 the	 ac tua l	 number	 o f	 pa t i en t s	 who	 have	 been	
intervened.	Statistical	comparison	of	the	2	phases	is	 less	
meaningful,	 and	 therefore	 the	 actual	 number	 of	 patients	
intervened	is	presented	instead.
Data	extraction	and	collection	
	 The	 grand	 populations	 of	 eligible	 chronic	 patients	
are	 retrieved	 from	 the	 clinic	 computer	 system.	 The	
lists	 of	 samples	 of	 patients	 for	 review	 are	 randomly	
generated	 by	 a	 custom-made	 randomization	Macro	
in Microsoft EXCEL. They are then reviewed by 
the	 principal	 investigator	 against	 the	 5	 audit	 criteria.	
Computerized	 records	 are	 the	 standard	 operational	
notes	 used	 in	 the	 clinic,	 and	 so	 they	 were	 the	main	
documentation	 reviewed.	 In	 case	 of	 uncertainty,	 the	
paper	records	were	also	reviewed.
Interventions
Identification of deficiencies and implementation of 
changes 
	 After	the	completion	of	the	first	phase,	a	systematic	
review	was	 undertaken	 by	 the	 principal	 investigator	
to	 identify	 the	 deficiencies	 in	 the	 process	 of	 care.	
The	 principal	 investigator	 also	 sought	 advice	 from	 his	
senior	 colleagues	 and	 the	 clinic	 doctor-in-charge.	The	
identified	 areas	 for	 enhancements	 and	 improvement	
changes	are	summarized	in	Table 4.	
	 After	 ident i fying	 the	 areas	 for	 enhancement ,	
the	 principal	 investigator	 discussed	 with	 his	 clinic	
supervisor	 on	 the	 proposed	 improvement	measures.	
A	 clinic	meeting	 involving	 the	 principal	 investigator,	
the	 cl inic	 supervisor,	 the	 nursing	 officer,	 a	 nurse	
representat ive,	 a	 dispenser,	 and	 a	 member	 of	 the	
clerical	 staff	was	 held	 to	 introduce	 the	 importance	 of	
smoking	 cessation	 activities.	The	 initial	 findings	 of	 the	
first	 phase,	 the	 setup	 of	 the	 audit,	 and	 the	 proposed	
improvement	 changes	were	discussed.	The	consensus	of	
the	meeting	was	 then	 relayed	 to	 all	 nursing,	 supporting	
and	clerical	 team	members.
	 A	 formal	 invi ta t ion	 le t ter	 deta i l ing	 the	 audi t	
design	was	 sent	 to	 all	 other	medical	 staff	 of	 the	 same	
department	 to	 seek	 their	 assistance	 on	 the	 project.	A	
second	 reminder	was	 also	 delivered	 to	 each	 Evening,	
Sunday,	 and	 Public	 Holiday	 clinic	 relieving	 doctor	
when	he	 /	 she	 first	came	back	 to	 the	clinic	 for	 relieving	
duties.
	 Furthermore,	 during	 the	 review	 of	 the	 first	 phase	
data,	 it	 was	 noted	 that	 there	 had	 been	 a	wide	 range	 of	
clinical	 performance	 on	 smoking	 cessation	 intervention	
within	 the	medical	 team.	The	 principal	 investigator	
then	 approached	his	 colleagues	 individually	 to	 relay	 the	
importance	 of	 anti-smoking	 activities,	 to	 discuss	 any	
barrier	 to	practice,	 and	 to	 seek	 their	 active	participation	
in	the	second	phase.
Outcome measures 
	 The	 outcome	 measures	 in	 th i s	 audi t	 re fe r	 to	
improvement	achieved	across	 the	2	phases,	 and	whether	
the	final	results	met	pre-set	standards.
Table 3: Frequencies of patients derived from the pilot audits in each phase
	 	 First phase Second phase
Pilot study	 	
	 Smoker	 16/138	 14/138
	 Non-smoker	 120/138	 119/138
	 Unknown smoking status	 2/138	 5/138
Total patient	 18352	 19421
Total smoker estimated	 18352	x	16/136	=	2159	 19421	x	14/133	=	2044
Sample size for criteria 2, 3	 327	 324
Patient records to be reviewed	 327	x	136/16	x	110%	=	3058	 324	x	133/14	x	110%	=	3386
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Table 4: Areas for enhancement in the first phase and improvement measures
Deficiencies identified Improvement measures
System:
● Lack of a formal integrated clinic   ● Currently, there is no established unified guideline on anti-smoking activities in the author’s   
	 protocol	for	anti-smoking	activities.	 	 clinic.	Therefore,	a	series	of	tailor-made	anti-smoking	initiatives	were		adopted	locally	for	
	 	 	 	 implementation	in	the	clinic.
	
● Lack of on-site smoking cessation. ● Liaison with a local community organization has been made to introduce an alternative   
	 clinic.	 	 referral	centre.
● Lack of an updated list of referral  ● Updated information on smoking cessation centres has been dispatched and communicated
	 destinations	by	doctors	and	nurses.	 	 with	all	clinicians	and	nursing	staff.
Practice:
● Lack of a central documentation of  ● Establishment of a formal logbook to collect data on referrals.
	 referrals	 to	Smoking	Counseling	and	
	 Cessation	Centres.
	
● Lack of updated resources on smoking  ● Procurement of updated pamphlets for distribution in the waiting area and nursing station.
 cessation. ● Procurement of updated posters.
● Lack of educational information. ● Monthly afternoon talk on smoking cessation conducted by nursing colleagues.
  ● Showing of anti-smoking videos in the waiting area.
	
Staff:
● Lack of integral team involvement to  ● Summon of a clinic meeting to relay the anti-smoking message to all  nursing, supporting, 
	 promote	smoking	cessation.	 	 clerical,	and	dispensary	staff.
  ● Encouragement was given to all nursing staff, supporting staff and clerical staff to offer 
	 	 	 brief	anti-smoking	advice	to	patients.
  ● Emphasis has been placed on building a team approach to intervene smoking patients, 
	 	 	 and	to	create	an	anti-smoking	atmosphere	within	the	clinic.
● Lack of involvement from, and  ● A letter detailing the aim, setup and implementation of the audit was sent to all doctors in 
	 communication	channel	for	 	 the	same	department	before	commencement	of	the	audit.
	 	relieving	/	 locum	doctors.
  ● A dedicated newsletter with detailed information on various local (both public 
	 	 	 and	community)	smoking	cessation	centres	was	sent	 to	all	doctors	in	the	same	
	 	 	 department	during	the	implementation	period.	
Dispensary:
● Lack of access to medications,  ● A Quick Reference Card with practical examples on the prescription of various  
	 e.g.	NRTs,	Bupropion,	or	Varenicline.	 	 pharmacological	agents	was	placed	in	every	consultation	room	to	facilitate	prescription	as	 	
	 	 	 self-financed	items.
Reminder	system:
● Lack of tools to facilitate the  ● A stack of specially designed Treatment Sheet has been placed in each room to facilitate 
	 incorporation	of	anti-smoking		 	 	 clinicians	to	direct	eager	smokers	to	nursing	station	for	further	actions.	
 activities into clinical practice. ● A concise Consultation Notes Template in the computer system has been set up to ease 
	 	 	 documentation.
● Lack of reminder to clinicians  ● A clipboard carrying the Quick Reference Card and the Treatment Sheet was placed 
	 on	anti-smoking	activities.	 	 on	each	consultation	table	as	a	reminder.	
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Statistical	methods	
	 Chi-square	 (wi thout	 Yate’s	 correct ion	 as	 the	
sample	 s izes	 a re	 l a rge)	 i s	 employed	 to	 eva lua te	
statistical	 significance.	Two-tailed	p	 values	 are	 used	 to	
demonstrate	statistical	significance.	For	criteria	4	and	5,	
the	 actual	 numbers	 of	 subjects	 are	 small.	Therefore,	 the	
actual	frequencies	are	presented.
Results
	 The	results	of	 the	2	audit	phases	are	summarized	in	
Table 5.
	
	 In	 both	 phases,	 criteria	 1	 to	 3	 did	 not	meet	 pre-set	
standards,	 although	 there	were	 statistically	 significant	
improvements.	 Criterion	 4	 shows	 an	 apparent	 drop	 in	
the	performance,	but	 that	could	be	attributed	to	 the	very	
small	number	of	subjects.
	 Across	 the	2	phases,	 there	 is	a	 large	 increase	 in	 the	
number	 of	 eager	 smokers	 identified	 (from	 1	 to	 12).	 It	
is	 due	 to	 an	 enhanced	 assessment	 of	 the	willingness	 to	
quit.	 For	 the	 actual	 number	 of	 patients	 quitted	 smoking	
during	 the	 audit	 period,	 there	 is	 none	 in	 the	 first	 phase	
while	 there	 are	 4	 in	 the	 second	 phase.	 For	 the	 total	
number	 of	 smokers	 referred	 to	 a	 smoking	 cessation	
centre,	 there	 is	 no	 data	 available	 in	 the	 first	 phase,	
while	 there	 are	 41	 in	 the	 second	 phase	 as	 demonstrated	
in	a	prospective	logbook.
Discussion
Why	were	some	pre-set	standards	not	met?
	 The	 pr incipal	 invest igator ’s	 c l in ic	 i s	 a	 large	
regional	 GOPC	 with	 evening,	 sunday	 and	 publ ic	
holiday	 clinics.	Many	 patients	 who	 have	 defaulted	
appointment	 in	 their	 original	 district	 clinics	 come	 to	
have	 follow	 up	 in	 this	 clinic	 as	 the	 final	 resort.	Many	
of	 them	 are	 seen	 only	 once	 or	 infrequently	 over	 a	
one-year	 period,	 and	 that	 leaves	 little	 opportunity	 for	
preventive	activities.	
	 Furthermore,	 patients	with	 stable	 chronic	 illnesses	
are	 increasingly	 given	 longer	 follow-up	 appointments.	
Longer	 follow-up	 intervals	 result	 in	 fewer	 encounters	
for	opportunistic	preventive	interventions.
	 A	 final	 reason	 for	 the	 inability	 to	meet	 standards	
could	 be	 linked	 to	 human	 factors.	 During	 the	 data	
collection	 of	 the	 first	 phase,	 it	 had	 been	 noticed	 that	
there	was	 a	wide	 range	 of	 performance	 among	different	
clinicians.	 This	 large	 deviation	 was	 again	 observed	
when	 the	 principal	 investigator	 reviewed	 the	 second	
phase	records.	An	impression	was	that	several	clinicians	
were	 not	 performing	 according	 to	 expectation	 in	 the	
process	 of	 care.	 This	 impression	 of	 the	 pr incipal	
investigator,	 however,	 cannot	 be	 quantified	 because	
patients	 are	 frequently	 seen	 by	more	 than	 one	 clinician	
over	the	one-year	period.
Table 5: Results of the 2 audit phases
	 	 First phase Second phase Standard p-value
Criterion 1	 87.6%	 96.1%	 100%	 0.0001
(ASK)	 (2680/3058)	 (3254/3386)	
Criterion 2	 33.3%	 58.0%	 100%	 0.0001
(ADVICE)	 (108/324)	 (181/312)	
Criterion 3	 4.6%	 43.6%	 100%	 0.0001
(ASSESS)	 (15/324)	 (136/312)	
Criterion 4	 100%	 66.7%	 100%	 /
(ASSIST)	 (1/1)	 (8/12)	
Criterion 5	 100%	 100%	 100%	 /
(ARRANGE)	 (1/1)	 (12/12)	
No. of quitters	 0	 4	 /	 /
No. of patients referred SCCC	 N/A	 41	 /	 /
(No. of quitters = number of smokers whose smoking status changed from Smoker to Ex-smoker during the one-year second phase.)
(SCCC = Smoking Counseling and Cessation Centre.)
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Impact	on	patient	care
	 The	 benefits	 brought	 about	 by	 the	 implementation	
were	 not	 limited	 to	 service	 improvement,	 but	 also	 a	
change	 in	 attitude	 of	 all	 clinic	 staff.	Many	 dedicated	
colleagues	continued	to	keep	updating	patients’	smoking	
status,	 assessing	 patient’s	willingness	 to	 quit	 or	 even	
referring	patients	 to	SCCC	after	 the	 formal	 audit	 period	
has	ended.	This	 is	 indeed	an	atmosphere	and	motivation	
brought	about	by	the	audit,	continuing	the	audit spiral.28
Limitations
	 One	 limitation	 of	 this	 audit	 is	 that	 it	 is	 not	 easy	
to	 mot iva te	 locum	 doctors	 to	 adhere	 wel l	 to	 the	
audit	 protocol.	 The	 resident	 doctors	 of	 the	 principal	
investigator ’s	 clinic	 are	 on	 average	more	motivated	
because	 there	 are	more	 regular	 liaisons	 during	 the	 audit	
period.
	 Another	weakness	 of	 the	 audit	 is	 that	 the	 record	
reviewing	 process	 demands	 a	 high	 professional	 time	
input.	Although	 the	 computer	 system	 is	 able	 to	 capture	
the	smoking	status	of	patients,	 it	 is	not	possible	 to	draw	
such	 data	 by	 the	 frontline	 clinician	without	 the	 help	 of	
the	central	 information	 technology	 (IT)	 team.	Currently,	
the	 reviewing	 process	 is	mainly	manually	 performed.	
Enhancement	 in	computer	 system	and	close	 liaison	with	
the	 IT	 team	 in	planning	would	probably	 facilitate	 future	
audits.
Future	directions
	 Further	 audits	 should	 be	 considered	 to	 assess	
smoking	 cessation	management	 among	 patients	without	
chronic	 illness,	 and	 also	 to	 review	 the	management	
provided	by	nurses.
Conclusions
	 By	completing	a	clinical	audit	cycle	and	combining	
a	 targeted	 team	 approach	 to	 implement	 changes,	 it	 is	
possible	 to	 bring	 about	 significant	 improvements	 in	
the	 process	 of	 care	 of	 smoking	 cessation	 intervention.	
However,	systems	limitations	and	human	factors	prevent	
clinical	 performance	 to	 approach	 pre-set	 standards.	
Further	 changes	 in	 care	 delivery	 are	 expected	 to	 result	
in	 further	 improvement.	 Further	 audits	 encompassing	
patients	without	 chronic	 illnesses,	 or	 including	 nursing	
interventions,	should	be	considered.
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Summary
 Hypertension is the most common chronic disease 
among people aged 15 years or above in Hong Kong. 
It is the second commonest reason for consultation 
i n p r i m a r y c a r e .  T h e R e f e r e n c e F r a m e w o r k f o r 
Hypertension Care for Adults in Primary Care Settings 
was publ ished by the Task Force on Conceptua l 
Model and Preventive Protocols of the Working Group 
on Primary Care in 2010 in order to translate medical 
research evidence into health benefit of our population. 
I t is a consensus document endorsed by var ious 
stakeholders including patient groups and primary care 
doctors and considered to be the most appropriate 
and feasible application of evidence to Hong Kong’s 
primary care. This article discusses how the family 
doctor can translate the Framework recommendations 
on hypertension management into daily practice. It is 
believed that adoption of the reference framework can 
lead to more effective management of this common 
chronic condition in primary care settings.
摘要
 高血壓是15歲或以上香港人最常見的慢性疾病，也
是基層醫療中的第二種最常見診症原因。為將醫學研究結
果轉化成病人的健康效益，基層醫療概念模式和預防工作
常規專責小組在2010年出版了治理成年人高血壓的參考
概覽。這份文獻的制訂得到各方面人仕的共識，其中包括
病人團體和基層醫療醫生的利益相關者。它被認為是在香
港基層醫療最合適和可行的做法。本文論述家庭醫生可以
如何將參考概覽中的建議應用在日常高血壓的預防及治療
上。我們認為參考概覽的採用能在基層醫療更有效地處理
這常見的慢性病。
HK Pract  2012;34:76-83
Introduction
	 Hypertension	 is	 the	 commonest	 chronic	 disease	 in	
Hong	Kong	with	 a	 prevalence	 of	 27%	 among	 people	
aged	 15	 years	 or	 above.1	 It	 is	 the	 second	 commonest	
reason	 for	 consultation	 in	 primary	 care.2	 The	 evidence	
on	 the	 association	 between	 high	 blood	 pressure	 and	
premature	 death	 and	 stroke	 has	 been	 known	 since	 the	
publication	 of	 the	 Society	 of	Actuaries	 study	 on	 body	
build	 and	 blood	 pressure	 in	 1959.3	 Tens	 of	 thousands	
of	 research	 studies	 confirmed	 the	 harm	of	 hypertension	
and	 the	 benefit	 of	 treatment	 to	 lower	 blood	 pressure.	
The	 Prospective	 Study	 Collaboration	 (PSC)	 meta-
analysis	 of	 over	 a	million	 subjects	 from	 61	 studies	
concluded	 that	 at	 all	 blood	 pressure	 levels	 down	 to	
115/75	 mmHg,	 a	 10mmHg	 systolic	 blood	 pressure	
(SBP)	 or	 a	 5mmHg	 diastolic	 blood	 pressure	 (DBP)	
reduction	 is	 associated	with	 a	 40%	 and	 30%	 relative	
risk	 reduction	 (RRR)	 in	 stroke	 and	 other	 vascular	
mortalities	 respectively.4	 	 Other	 studies	 have	 shown	
that	 a	 reduction	 of	 as	 little	 as	 2	mmHg	 in	DBP	 could	
reduce	 cardiovascular	 complications	 significantly.5	
Many	 drugs	 have	 been	 shown	 to	 be	 e f fec t ive	 in	
lowering	blood	pressure	and	reduction	of	cardiovascular	
complications.6,7	 	
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	 Translation	 of	 medical	 research	 evidence	 into	
health	 benefit	 of	 the	 population	 is	 always	 a	 challenge.	
Wilber	and	Barrow	described	 the	“rule	of	halves”	 in	 the	
rates	of	detection,	 treatment	and	control	of	hypertension	
were	 all	 around	 50%	 among	 the	 relevant	 populations	
in	 the	U.S.	 in	 1972,8	which	was	 later	 also	 observed	 in	
many	 other	 populations.9,10	 The	Hong	Kong	 Population	
Health	 Survey	 2003-2004	 found	 that	 only	 44.5%	 of	
those	 with	 high	 blood	 pressure	 were	 diagnosed.1	 A	
survey	on	 the	management	of	hypertension	among	 local	
primary	 care	 doctors	 found	 that	 only	 30%	would	 start	
treatment	 for	 patients	with	 blood	 pressure	 >140/90	 and	
the	 control	 targets	 of	 SBP	 <140	 and	DBP	 <90	were	
adopted	 by	 only	 26%	 and	 47%	 of	 the	 surveyed	 doctors	
respectively.11
	 To	 promote	 bes t	 p rac t ice ,	 the	 Wor ld	 Hea l th	
Organisation	 (WHO)12	 and	many	 overseas	 national	
professional	 bodies	 have	 developed	 guidelines	 on	
the	 treatment	 of	 hypertension.7,	 13,	 14	 Similar	 initiative	
was	 also	 called	 for	 to	 assure	 the	 quality	 of	 care	 of	
hypertension	for	our	population	in	Hong	Kong.11	 	 	 	 	
The Hong Kong Reference Framework 
	 Th e	 Hong	 Kong	 Re f e r e n c e	 F r amewo rk	 f o r	
Hypertension	Care	 for	Adults	 in	 Primary	Care	 Settings,	
which	 i s	 ava i l ab le	 on l ine	 (www.fhb .gov .hk	 and	
www.pco.gov.hk),15	 was	 first	 published	 in	 2010	 to	
address	 the	 needs	 of	 our	 local	 practice,	 and	 is	 being	
updated	 regularly.	 It	 is	 a	 consensus	 document	 endorsed	
by	 various	 stakeholders	 including	 patient	 groups	 and	
primary	 care	 doctors	 and	 is	 considered	 to	 be	 the	most	
appropriate	 and	 feasible	 application	 of	 evidence	 to	
Hong	Kong’s	 primary	 care.	 The	 framework	 consists	 of	
a	 core	 document	 and	 eight	modules.	 Summary	 of	 the	
hypertension	reference	framework	is	shown	in	Figure 1.
	 The	 core	 document	 describes	 the	 principles	 of	 the	
management	 of	 hypertension	 from	 primary	 prevention	
to	 patient	 empowerment	 for	 self-management,	 and	
makes	 evidence-based	 recommendations	 for	 practice	 as	
summarized	in	Table 1.	 	 	
Translating research evidence into daily practice
	 The	 commi tment	 o f	 bo th	 pub l ic	 and	 p r iva te	
primary	 care	 doctors,	 to	 the	 prevention,	 detection	 and	
management	 of	 adults	with	 hypertension	 is	 of	 primary	
importance.	We	 need	 to	 assure	 the	 public	 that	 primary	
care	 doctors	 have	 the	 needed	 competence	 and	 support	
services	to	manage	hypertension	to	a	high	standard.	 	 	 	
Prevention	&	Screening	of	Hypertension	
	 Every	 primary	 care	 consultation	 is	 an	 opportunity	
for	 preventing	 and	 screening	 hypertension.	 People	 in	
Hong	Kong	 consult	 primary	 care	 an	 average	 of	 8	 times	
a	year	and	80%	of	 the	population	would	have	consulted	
primary	 care	 at	 least	 once	 within	 a	 year16,17	 which	
provides	 plenty	 of	 opportunities	 for	 doctors	 “to	 advise	
individuals	 at	 increased	 risk	of	 developing	hypertension	
and	 patients	 with	 hypertension	 to	maintain	 optimal	
body	weight,	 restrict	dietary	salt,	abstain	 from	smoking,	
and	 pract ise	 heal thy	 l i fes tyles”,	 and	 to	 carry	 out	
opportunistic	 blood	 pressure	measurement	 for	 all	 adults	
aged	 18	 or	 above.15	 Classification	 of	 blood	 pressure	
and	 recommendations	 for	 frequency	 of	 blood	 pressure	
screening	is	summarized	in	Table 2.13
	 To	 ensure	 efficient	 service	 delivery	 to	 all	 eligible	
patients,	 a	 system	 for	 identifying	 eligible	 patients,	
accura te	 b lood	 pressure	 measurement	 (Module	 2	
of	 Reference	 Framework),	 counseling	 on	 lifestyle	
modifications,	 recalling	 high-risk	 patients,	 and	 proper	
record	 keeping	 must	 be	 incorporated	 into	 routine	
practice.	 There	 should	 be	 an	 agreed	 protocol	 among	
primary	 care	 team	members	 on	who,	when,	what	 and	
how	 various	 tasks	 are	 to	 be	 carried	 out.	 The	medical	
record	must	 provide	 continuous	 recording	 and	 promote	
easy	 retrieval	 of	 blood	 pressure	measurements	 as	well	
as	 data	 on	 lifestyle,	 health	 advice,	 cardiovascular	 risk	
factors	 and	 other	 relevant	 parameters.	An	 illustration	
o f	 a	 supp l emen ta ry	 r eco rd	 shee t	 o r	 modu le	 fo r	
hypertension	care	is	shown	below	(Figure 2).	 	 	 	 	
	 To	 serve	 the	purpose,	dietary	 and	physical	 exercise	
advice	 needs	 to	 be	 very	 specific	 (Modules	 5	 and	 6	 of	
the	Reference	 Framework).15	 Repeated	 counseling	 and	
coordinated	 input	 from	 different	 health	 professionals	
including	 dieticians,	 physiotherapists	 (for	 exercise	
counseling),	 nurses	 from	 smoking	 cessation	 counseling	
clinic,	 are	 needed	 to	 enhance	 the	 effectiveness	 of	
var ious	 preventive	 advice. 16,	 18	 I t	 cannot	 be	 over-
emphasized	that	screening	of	hypertension	is	worthwhile	
only	 if	 patients	 with	 suboptimal	 BP	 are	 adequately	
reviewed	 in	 order	 to	 establish	 the	 diagnosis	 and	 to	
provide	 appropriate	 treatment.	 Hypertension	 should	
confirm	 if	 blood	pressure	 is	 persistently	high	 in	 at	 least	
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Figure 1: One-page summary of the Hong Kong Reference Framework for Hypertension Care for Adults in 
Primary Care Settings
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Table 1:  Recommendations of the Hong Kong Reference Framework for Hypertension Care for Adults in Primary Care 
Settings15
Prevention of Hypertension – Adoption of a Healthy Life Style
1	 Advise	 individuals	 at	 risk	 of	 developing	 hypertension	 and	 patients	with	 hypertension	 to	maintain	 optimal	 body	weight,	 restrict	 dietary	 salt,	
abstain	from	smoking,	and	practise	healthy	lifestyles.	
Early Identification of People with Hypertension
2	 Opportunistic	 blood	 pressure	measurement	 in	 all	 adults	 from	 18	 years	 of	 age	 at	 least	 every	 2	 years,	with	 appropriate	 follow	 up	 actions	
according	to	blood	pressure	results
	 •	 BP120-139/80-89	mmHg:	re-check	1	year	+	lifestyle	
	 •	 BP140-159/90-99	mmHg:	confirm	within	2	months	+	lifestyle	
	 •	 BP160-179/100-109	mmHg:	evaluate	within	1	month	+	lifestyle,	and	drug	treatment	if	high	blood	pressure	is	confirmed.
	 •	 BP>180/110	mmHg:	further	evaluation	within	1	week+	lifestyle,	and	drug	treatment	if	high	blood	pressure	is	confirmed.	 	
Management of Adults with Hypertension
3	 Initial	comprehensive	assessment	for	co-existing	cardiovascular	risk	factors	or	other	problems	that	may	affect	prognosis	and	treatment
	 •	 Cigarette	smoking
	 •	 Obesity
	 •	 Physical	 inactivity
	 •	 Dyslipidaemia
	 •	 Diabetes	mellitus
	 •	 Microalbuminuria	or	estimated	GFR	<	60	ml/min
	 •	 Age	(older	than	55	for	men,	65	for	women)
	 •	 Family	history	of	essential	hypertension	and	premature	cardiovascular	disease	(men	under	55	or	women	under	65)
4	 Adoption	of	a	healthy	lifestyle	with	the	following	modifications
 • Encourage overweight (BMI ≥ 23) and obese (BMI ≥ 27.5) hypertensive patients to lose weight
	 •	 Increase	consumption	of	fruits	and	vegetables	to	5	portions	per	day,	and	reduce	total	and	saturated	fat	consumption
	 •	 Reduce	salt	 intake	to	less	than	5	g	(around	1	teaspoon	of	table	salt)	per	day	and	not	to	use	added	salt.
	 •	 Increase	 level	of	physical	activity	and	take	regular	exercises	(	aerobic	exercise	 	>30	min	per	day	and	resistance	exercise	 	8-10	sets	at	8-12	
repetitions	per	set	2-3	times	per	week).	
	 •	 Reduce	alcohol	intake	to	no	more	than	two	drinks	per	day	for	men	and	1	drink	per	day	for	women
	 •	 Encourage	to	stop	smoking	and	refer	to	smoking	cessation	services	if	needed.
5 Start drug treatment in patients with sustained BP ≥ 140/90 mmHg despite lifestyle modification or if target organ damage is present.  Start 
with	 angiotensin	 converting	 enzyme	 inhibitor	 (ACEI)	 /	Calcium	Channel	Blocker	 (CCB)	 /	 thiazide	 diuretic,	 switch	 if	 there	 is	 side	 effect,	 add	
if	 inadequate	BP	control.
6	 Goal	of	 therapy	for	simple	hypertensive	patients	 is	<140/90	mmHg,	and	<130/80	mmHg	for	patients	with	hypertension	and	diabetes	or	chronic	
kidney	diseases	respectively.
7	 Regular	follow	up	after	 initiating	antihypertensive	drug	treatment
	 •	 Every	2	weeks	until	 blood	pressure	goal	 is	 achieved.	More	 frequent	 visits	may	be	 indicated	 for	 patients	with	BP	160/100	mmHg,	or	with	
complications.	
	 •	 Every	6-12	weeks	after	blood	pressure	goal	 is	achieved
	 •	 Annual	 assessment	of	 	 lifestyle,	 drug	adherence	 and	 side	 effects,	 family	history	of	premature	 coronary	heart	 diseases,	BMI,	urine	protein,	
renal	function,	 lipid	profile,	and	fasting	blood	sugar	
8	 Referrals	 to	hospital	or	specialists	are	indicated	for	the	following	patients
	 Immediate	referral	 to	hospital	
	 •	 Malignant	hypertension	
	 •	 Accelerated	hypertension	DBP	>130mmHg	and	retinal	haemorrhage
	 •	 Persistent	BP	>220/120	mmHg	despite	rest	or	drug	treatment
	 •	 Pregnancy	and	BP	140/90	mmHg	and	>20	weeks	gestation,	or	signs	and	symptoms	of	pre-eclampsia
	 Referral	 to	specialists
	 •	 Suspected	secondary	hypertension
	 •	 Patients	aged	30	or	below
	 •	 Hypertension	in	pregnancy	<	20	weeks	gestation	without	signs	or	symptoms	of	pre-eclampsia.	
	 •	 Patients	with	progressive	complications
	 •	 Medication	problems	such	as	severe	drug	reaction,	 treatment	resistance,	multiple	drug	intolerance,	or	multiple	drug	contraindications
Adapted from the Hong Kong Reference Framework for Hypertension Care for Adults in Primary Care Settings15
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Table 2: Classification of blood pressure and recommendations for frequency of blood pressure screening (Adapt from 
the seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of 
High Blood Pressure) 13
Blood  Initial Blood Pressure   Recommended minimum review  Action
pressure  (mmHg)	Note	2  period Note	3
classification Note	1  	 	 	
	 	 Systolic Diastolic 	
Normal	 <120	 <80	 Recheck	in	2	years	 Encourage	to	adopt	
	 	 	 	 (annual	check	for	adult	 	 healthy	lifestyle
	 	 	 	 aged>75	years)	
Pre-	hypertension	 120-139	 80-89	 Recheck	in	1	year	 Lifestyle	modification
Stage	I	hypertension	 140-159	 90-99	 Confirm	within	2	months	Note	4	 Lifestyle	modification
Stage	II	hypertension	 160-179	 100-109	 Evaluate	within	one	month	 •	 Treat	within	one	month
	 	 	 	 	 •	 Lifestyle	modification
	 	 >180	 >110	 Further	evaluation	within	one	week	 •	 I f 	 h i gh	 b lood	 p r e s su r e	 i s	
confirmed,	 drug	 t reatment	
should	be	commenced	
	 	 	 	 	 •	 May	warrant	 urgent	 referral	
if	 patient	 presents	 features	
s u g g e s t i v e 	 o f 	 m a l i g n a n t	
hypertension	(Refer	to	Box	2)
	 	 	 	 	 •	 Lifestyle	modification	
Note 1. The classification is based on the average of 3 or more properly measured seated blood pressure readings, at least 1 week apart on office visits.21
Note 2. If systolic and diastolic categories are different, follow recommendations for shorter review period.
Note 3. Modify review period according to reliable information about past blood pressure measurements, other cardiovascular risk factors, or target organ 
diseases.
Note 4.  Updated NICE guideline in August 2011.7 If the clinic blood pressure is 140/90 mmHg or higher, offer ambulatory blood pressure monitoring (ABPM) 
to confirm the diagnosis of hypertension. If a person is unable to tolerate ABPM, home blood pressure monitoring (HBPM) is a suitable alternative to 
confirm the diagnosis of hypertension. When using ABPM to confirm a diagnosis of hypertension, ensure that at least two measurements per hour are 
taken during people’s usual waking hours (for example, between 08:00 and 22:00). Use the average value of at least 14 measurements taken during the 
person’s usual waking hours to confirm a diagnosis of hypertension. When using HBPM to confirm a diagnosis of hypertension, ensure that: for each 
blood pressure recording, two consecutive measurements are taken, at least 1 minute apart and with the person seated and blood pressure is recorded 
twice daily, ideally in the morning and evening and blood pressure recording continues for at least 4 days, ideally for 7 days. Discard the measurement 
taken on the first day and use the average value of all the remaining measurements to confirm a diagnosis of hypertension.
3	 properly	measured	 seated	 blood	 pressure	 readings,	
each	 at	 least	 1	week	 apart	 during	 office	 visits.	 People	
with	BP	 >180/110	mmHg	 should	 be	 further	 evaluated	
within	 1	week;	 those	with	 levels	 of	 160-179/100-109	
mmHg	 should	 be	 evaluated	 again	 within	 1	 month;	
while	 those	with	 levels	of	140-159/90-99	mmHg	should	
be	re-checked	within	2	months	to	confirm	the	diagnosis,	
in	 addition	 to	 providing	 lifestyle	 advice	 (Table 1).15	
Med i c a l 	 r e co r d s	 o f 	 p a t i e n t s 	 w i t h	 r a i s ed	 b l ood	
pressure	 should	 be	 flagged	 for	 repeat	 blood	 pressure	
measurements.	 Furthermore	 the	 practice	 should	 set	 up	
a	 recall	 system	 to	 remind	 patients	 due	 for	 follow	 up.	
24-hour	 ambulatory	 blood	 pressure	monitoring	 (ABPM)	
and	home	blood	pressure	monitoring	 (HBPM)	 for	 seven	
consecutive	days	are	suitable	alternatives	for	confirming	
the	 diagnosis	 of	 hypertension.7	 A	modeling	 study	 in	
the	United	Kingdom	 suggested	 that	 24-hour	 ambulatory	
blood	 pressure	may	 be	 the	most	 cost-effective	method	
for	 d iagnos ing	 hyper tens ion19	 bu t	 i t	 needs	 to	 be	
confirmed	 by	 empirical	 clinical	 studies	 before	 it	 can	 be	
recommended	as	a	routine	practice.	
Management	of	Adults	Hypertension	
	 Patients	 confirmed	 to	 have	 hypertension	 should	
be	 evaluated	 for	 possible	 secondary	 hypertension,	 co-
existing	 cardiovascular	 risk	 factors,	 or	 target	 organ	
damage	 (Table 1 ) .	 The	 deta i ls	 for	 evaluat ion	 on	
possible	 secondary	 hypertension	 and	 target	 organ	
damage	 assessment	 have	 been	 described	 in	Module	
3 	 a n d 	 Modu l e 	 4 	 o f 	 t h e 	 R e f e r e n c e 	 F r amewo r k	
respectively.15	 To	 achieve	 this,	 direct	 access	 to	 reliable	
and	affordable	investigation	services	is	essential.	 	 	
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	 The	 treatment	of	hypertension	starts	with	 lifestyle	
modif ica t ions	 s imi lar	 to	 those	 recommended	 for	
prevention,	 therefore	 support	 from	 relevant	 multi-
d isc ip l inary	 serv ices	 i s	 necessary .	 Pa t ients	 wi th	
ma l ignan t	 hype r t ens ion	 (DBP	 >	 130	 and	 heavy	
prote inur ia ,	 papi l loedema	 or	 encephalopathy)	 or	
acce lera ted	 hyper tens ion	 (DBP	 >	 130mmHg	 and	
retinal	 hemorrhage)	 should	 be	 referred	 to	 the	 hospital	
immedia te ly .	 Drug	 t r ea tment	 shou ld	 be	 s t a r t ed ,	
i f	 	 hyper tens ion	 i s	 conf i rmed ,	 wi th in	 one	 week	
for	 patients	 with	 blood	 pressure	 >180/110	 mmHg,	
within	 one	month	 for	 patients	 with	 blood	 pressure	 of	
160-179/100-109	mmHg,	 and	 for	 those	with	 sustained	
b lood	 pressure	 o f	 140-159/90-99	 mmHg	 desp i te	
l ifestyle	 modifications	 for	 6	 months.	 Angiotensin	
conve r t i ng	 enzyme	 i nh ib i t o r s	 (ACEI ) , 	 c a l c i um	
channel	 blockers	 (CCB),	 and	 thiazide	 diuretics	 are	
recommended	 as	 first-line	 drugs	 for	 hypertension.	
Beta	blockers	 are	no	 longer	 recommended	as	 first	 line	
drugs	 for	 uncomplicated	 hypertension.	 The	 choice	
of	 d rug	 needs	 to	 be	 ind iv idua l ized	 accord ing	 to	
    
    HT  Initial Assessment HT  Follow up Assessment
Lens	&	Fundi	 	 	 	 	 	 	 	
Peripheral	Pulse	 	 	 	 	 	 	 	
Cardiovascular	Examination	 	 	 	 	 	 	
Fasting	Blood	Sugar	 	 	 	 	 	 	 	
Renal	Function	Test	 	 	 	 	 	 	
Urine	for	protein	/	albumin	 	 	 	 	 	 	
Lipids	 	 	 	 	 	 	 	
ECG	 	 	 	 	 	 	
Drugs	Regimen	 	 	 	 	 	 	
Others	 	
Figure 2:  Example of Medical Record Template for Continuing Health Assessment and Hypertensive Care
Health Assessment Chart -All Adults 
Date		 	 	 	 	 	 	 	 	 	
Family	History			 	 	 	 	 	 	 	 	
Weight	 	 	 	 	 	 	 	 	 	 	
Height	 	 	 	 	 	 	 	 	 	 	
BMI		 	 	 	 	 	 	 	 	 	
B.P.	 	 	 		 	 	 	 	 	 	 	 	
Drinking		 	 	 	 	 	 	 	 	 	
Smoking		 	 	 	 	 	 	 	 	 	
Exercise	 	 	 	 	 	 	 	 	 	 	
Diet	 	 	 	 	 	 	 	 	 	 	
Others		
other	 patient	 characteristics,	 e.g.	 diuretics	 should	 be	
avoided	 in	 patients	 with	 co-existing	 gout.	 A	 detailed	
description	 of	 the	 different	 anti-hypertensive	 drugs	 is	
described	 in	Module	 7	 of	 the	 reference	 framework.15	
Since	 some	 patients	 may	 be	 reluctant	 to	 commit	 to	
life-long	 anti-hypertensive	 drug	 treatment,	 continuing	
follow	 up	 and	motivational	 counseling	 by	 the	 family	
doctor	 would	 be	 helpful.	 A	 treatment	 algorithm	 is	
illustrated	 in	Figure 3.
	 Patients	 should	 be	 followed	 up	 two	weekly	 after	
init iat ion	 of	 drug	 treatment	 unti l	 the	 target	 blood	
pressure	 is	attained,	after	which	 the	follow-up	intervals	
can	be	 increased	 to	8-12	weeks.	
	 Over	 90%	 of	 the	 adult	 patients	 with	 hypertension	
can	 be	 managed	 exclus ive ly	 in	 pr imary	 care	 but	
r e f e r r a l 	 t o 	 s p e c i a l i s t s 	 f o r 	 f u r t h e r 	 managemen t	
i s 	 r e commended	 f o r	 p a t i en t s 	 w i t h	 h i gh	 r i s k	 o f	
complications	 or	 features	 suggestive	 of	 secondary	
hypertension	(Table 1).	
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The family doctor  
	 Local	 research	 has	 shown	 that	 having	 a	 regular	
family	 doctor	 is	 associated	with	 a	 higher	 likelihood	
of	 blood	 pressure	 screening	 and	 	 healthy	 lifestyle.20	
The	 family	 doctor’s	 emphasis	 on	 a	 continuing	 trusting	
doctor-patient	relationship	and	person-centred	care	is	the	
key	 to	 the	 appropriate	 translation	 of	 recommendations	
into	 individualized	 management.	 However,	 family	
doctors	 are	 only	 part	 of	 the	 larger	 health	 care	 delivery	
system,	 the	 proper	 function	 of	which	 requires	 the	 co-
ordinated	 input	 from	 different	 partners	 including	
patients,	 the	 government,	 specialists,	 academia,	 other	
health	 professionals,	 laboratories,	 community	 services.	
The	public	 and	medical	profession	need	 to	make	a	 joint	
effort	 to	prevent,	detect	and	manage	hypertension	better	
in	Hong	Kong	to	break	the	“rule	of	halves”.8	n
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Key messages
1.	 Hypertension	 is	 the	 commonest	 chronic	 disease	
among	 people	 aged	 15	 years	 or	 above	 in	 Hong	
Kong.	
2.	 Hypertension	 is	 the	 second	 commonest	 reason	 for	
consultation	in	primary	care.	
3.	 The	Reference	 Framework	 for	Hypertension	Care	
for	Adults	 in	 Primary	Care	 Settings	was	 published	
by	 the	 Task	 Force	 on	 Conceptua l	 Model	 and	
Preventive	 Protocols	 of	 the	Working	 Group	 on	
Primary	Care	 in	 2010	 in	 order	 to	 translate	medical	
r e sea rch	 ev idence	 in to	 hea l th	 benef i t	 o f	 our	
population.	
4.	 I t	 i s	 be l i eved	 tha t	 adop t ion	 o f	 the	 re fe rence	
framework	 can	 lead	 to	more	 effective	management	
of	hypertension	in	primary	care	settings.
5.	 Implementation	 of	 the	 recommendations	 requires	
appropriate	 organization	 of	 the	 work	 flow	 and	
medica l	 r ecords ,	 and	 adequa te	 suppor t	 f rom	
laboratory	and	other	health	professionals.
Figure 3:  Tr e a t m e n t  a l g o r i t h m  f o r  p e o p l e  w i t h 
Hypertension
Compelling	
indication	/	
contraindication	
over	choice	of	drug
Start	with	either	ACEI	(or	ARB	if	ACEI	intolerant),	
calcium	channel	blocker	or	thiazide-type	diuretic
No	response	or	not	 tolerated,	switch	to	another	drug.	
Inadequate	response	but	tolerated,	add	a	second	drug	
from	different	class
If	blood	pressure	goal	 is	still	not	reached,	 increase	
dose	or	consider	adding	third	drug	from	different	class
Refer	to	specialist	 if	blood	pressure	still	not	under	
control
Go	to	Appendix	1
Drug	treatment	for	essential	HT
↓
↓
↓
↓
Yes
No
↓
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Appendix 1: Compelling and Possible Indications and Contraindications for the Major Classes of Antihypertensive Drugs
Class of Drug Compelling Indications Possible Indications Compelling Contraindications Possible Contraindications
ACE	Inhibitors	(ACEI)	 Heart	failure,	 	 Proteinuria	renal	disease	 Pregnancy,	Bilateral	renal	 	 Renal	impairment
	 	 Left	ventricular	dysfunction,	 	 artery	stenosis,	 	 	 Close	monitoring	of	
	 	 Post	myocardial	 infarction,	 	 Hyperkalaemia	 electrolyte	and	
	 	 Diabetic	nephropathy	 	 	 	 creatinine	level	needed
Angiotensin	II	Receptor	 	 ACE	inhibitor	intolerance	 	 Pregnancy,	Bilateral	renal	 	 Renal	impairment
Blockers	(ARB)	 	 	 	 artery	stenosis,	Hyperkalaemia		 Close	monitoring	of	
	 	 	 	 	 	 	 electrolyte	and	creatinine		 	
	 	 	 	 	 	 	 level	needed
Alpha-Blockers	 Benign	prostatic	hypertrophy		 	 	 	 	 Orthostatic	hypotension
Beta-Blockers	 	 Angina,	Post	myocardial	 	 Heart	failure	 Asthma,	chronic	obstructive		 Peripheral	vascular	 	 	
	 	 infarction	Tachyarrhythmias	 (Metoprolol	succinate	 pulmonary	disease,	 disease
	 	 	 	 sustained	releasing,	 	 Heart	block
	 	 	 	 Bisoprolol,	and		
	 	 	 	 Carvedilol	at	medium	
	 	 	 	 to	high	dose)a	
Calcium	Channel	Blockers	 Elderly	patients,	 Peripheral	vascular	disease	 	 	 Congestive	heart	failure
(dihydropyridine)	 Isolated	systolic	hypertension
	
Calcium	Channel	Blockers	 Angina	 	 Heart	block	 Congestive	heart	
(rate	limiting,	e.g.	verapamil,	 	 	 	 	 	 	 failure,	combination	
diltiazem)	 	 	 	 	 	 with	beta-blockers
Thiazide	/	 thiazide-	 Heart	failure,	 	 Gout	 	 Dyslipidaemia,	Pregnancy,
like	Diuretics	 Elderly	patients,	 	 	 	 Sexually	active	males	
	 	 Isolated	systolic	hypertension
a.  Metoprolol succinate slow release, bisoprolol and carvedilol were shown by RCT to be beneficial in patients with heart failure. 
Clinical Quiz
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A n i n c i d e n t a l  f i n d i n g i n a  m a n w i t h 
psoriasis
King-man	Ho
Clinical history:
	 This	 gentleman	 known	 to	 have	 psoriasis	was	 found	 incidentally	 to	 have	 skin	
changes	as	shown.
What is the most likely diagnosis?
A.	 Erythrodermic	psoriasis	 	 	 C.	 Tinea	incognito
B.	 Mycosis	fungoides	 	 	 D.	 Ichthyosis	
The	Hong	Kong	Practitioner
Clinical Quiz  –  June / 2012
  Answer :
Name : 
Tel. No. : 
Address :
   
Date :  
Please	send	your	answer	to	:-	 	HKCFP
Room	802,	8/F.,	Duke	of	Windsor	Social	Service	Building,	15	Hennessy	Road,	Hong	Kong.

The	slide	and	the	question	were	prepared	by:
Dr King-man Ho, FRCP	(Glasg,	Edin),	MRCP	(UK),	FHKCP,	FHKAM	(Medicine)
Consultant Dermatologist-in-Charge,
Social	Hygiene	Service,	PHSB,	CHP,	DH
	 Readers	 are	 invited	 to	 participate	 in	 the	Clinical	Quiz.	 	A	 prize	 draw,	 sponsored	 by	 Pfizer	 Corporation	Hong	
Kong	Limited,	will	be	undertaken	among	 the	successful	entries.	 	For	entry	 into	 the	draw,	simply	answer	 the	question,	
fill	 in	 the	reply	slip	and	return	 it	 to	 the	College	by	18	August	2012.	 	Each	reader	 is	allowed	to	submit	one	entry	only.	
The	name	of	the	winner	and	the	answer	will	be	published	in	the	September	2012	issue.
Answer 
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Answer	to	last	month’s	Clinical	Quiz
Question:
	 An	11-year	old	girl	with	complex	genetic	disease	
presented	with	poor	bone	mineralization	 (see	 figure).	
She	 is	 on	 liquid	 formula	 via	G-tube.	 She	was	 never	
on	 total	 parenteral	 nutrition.	Her	 only	medication	
includes	 valproic	 acid,	which	 she	 has	 been	 on	 since	
the	 age	 of	 2	 for	 her	 seizure	 activities.	 Laboratory	
investigations	 were	 significant	 for:	 normal	 renal	
fuctions,	 low	bicarbonate	at	16	mmol/L	(16	mEq/dL),	
low	 phophate	 level	 at	 0.57	mmol/L	 (1.8	mg/dL),	 normal	
ionized	 calc ium	 and	 e levated	 a lkal ine	 phosphatase .	
Urine	 was	 posi t ive	 for	 glucose	 and	 protein.	 Further	
t e s t ings	 conf i rmed	 tha t	 she	 has	 h igh	 r ena l	 l o s s	 o f	
sodium,	 potassium,	 bicrbonate,	 amino	 acids,	 calcium	 and	
phosphorus.
Answer: 
C.		 Prolong	use	of	valproic	acid
	 T h e 	 p a t i e n t 	 p r e s e n t e d 	 w i t h 	 o s t e o p e n i a 	 a n d 	 b o n e	
demineralization.	 The	 laboratory	 investigations	 showed	 that	
she	 had	 renal	 Fanconi	 syndrome	with	 generalized	 proximal	
tubulopathy.	While	 prolong	 non-ambulation	 and	 poor	 diet	may	
lead	 to	 rickets,	 they	 did	 not	 explain	 the	 urine	 findings.	Genetic	
conditions	 such	 as	 Lowe’s	 syndrome	may	 present	with	 Fanconi,	
but	 it	 is	 usually	 assocaited	with	 renal	 dysfunction.	Hence,	 the	
most	 likely	 cause	 of	 her	 Fanconi	 syndrome	was	 secondary	 to	
the	 rare	 but	well	 documented	 side	 effect	 of	 the	 valproic	 acid.	
Valproic	acid	was	discontinued	and	 the	patient	was	supplemented	
with	 vitamin	 D,	 phosphorus	 and	 citrate.	 Her	 renal	 Fanconi	
resolved	 after	 12	months	 and	 she	 is	 currently	 not	 requiring	 any	
more	supplementation.
The	 winner	 of	 the	March	 2012	 Clinical	
Quiz	is	Dr Ho Tai Wai, David 
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Internet
What’s in the web for family physicians – 
multimedia musculo-skeletal resources
Alfred	KY	Tang	鄧權恩，Wilbert	WB	Wong	王維斌
A Practical Guide to Clinical Medicine: Musculo-
Skeletal Examination
http://meded.ucsd.edu/clinicalmed/joints.htm
	 This	 is	 a	website	 dedicated	 to	 physical	 examination	
skills	 of	 the	musculoskeletal	 system.	Clinical	 examination	
of	 all	 important	 joints	 of	 the	 body	 are	 covered	 at	 the	
website,	 and	 teaching	materials	 are	 all	 in	 multimedia	
format,	 well	 i l lustrated	 by	 photos	 and	 videos.	 More	
detailed	 descriptions	 of	 the	 shoulder,	 knee	 and	 low	 back	
examinations	are	included	as	these	are	the	more	commonly	
affected	 joints.	 Review	 of	 relevant	 anatomy,	 function	 and	
common	disorders	are	also	described	for	most	of	the	major	
joints.
Clinical assessment of the musculoskeletal system
http://www.arthritisresearchuk.org/~/media/Files/
Education/Student%20handbook%2011-1.ashx
	 This	 online	 handbook	 (2011	 Edition),	 published	 by	
Arthritis	 UK,	 provides	 revision	materials	 on	 regional	
examination	 of	 the	musculoskeletal	 system,	 as	well	 as	
screening	 and	 diagnosis	 of	 common	musculoskeletal	
problems.	 It	 outlines	 the	 simple	 screening	method,	GALS,	
by	which	 observing	 the	 gait, arms, legs	 and spine of	
a	 patient	 can	 give	 valuable	 clues	 to	 identification	 of	
potential	 neuromuscular	 disorders.	 Demonstrations	 of	
clinical	 examination	 techniques	 of	 spine,	 upper	 and	 lower	
limbs	are	also	available	in	the	handbook.
Procedural Skills Resources : Musculoskeletal 
h t t p : / / g u i d e s . l i b . u i o w a . e d u / c o n t e n t .
php?pid=5859&sid=36912
	 This	website	 is	maintained	 by	 the	University	 of	 Iowa	
Libraries.	The	webpage	 on	 Procedural	 Skill	 Resources	
Alfred KY Tang,	MBBS	(HK),	MFM	(Monash)
Wilbert WB Wong,	MBChB	(CUHK),	FHKCFP
Family Physicians in Private Practice.
Correspondence	to	 :	Dr	Alfred	K	Y	Tang,	Shop	3A,	 2/F,	Hsin	Kuang	Shopping	
Centre,	Wong	Tai	Sin,	Kowloon,	Hong	Kong	SAR.
	 	 E-mail:alfredtang@hkma.org
has	 a	 collection	 of	 videos	 and	 weblinks	 which	 cover	
many	 common	 medica l	 procedures .	 The	 sec t ion	 of	
musculosketa l	 medic ine	 has	 hyper l inks	 on	 c l in ica l	
skills	 involved	 in	 the	 physical	 examination	 of	 different	
joints	 of	 the	 body,	 and	 there	 are	 tutorials	 and	 videos	
on	 arthrocentesis	 of	 the	 knee	 joint	 and	 well	 as	 intra-
articular	 injections	 of	 the	 knee	 and	 shoulder	 joints.	 It	
is	 a	 useful	 site	 for	 family	 physicians	 looking	 for	 videos	
on	 physical	 examinat ion	 ski l ls	 as	 revis ion	 and	 also	
keeping	 themselves	 updated	 on	medical	 procedures	 of	
musculoskeletal	 system.
Guidelines for pain relief
http://www.nhmrc.gov.au/_files_nhmrc/publications/
attachments/cp104_3.pdf
	 This	 is	 a	 comprehensive	 guideline	 for	 acute	 pain	
management	 developed	 by	Australian	 and	 New	 Zealand	
Co l l ege	 o f	 Anae s t he t i s t , 	 and	 t h e	 Facu l t y	 o f	 Pa in	
Medicine	 (3rd	 edition,	 2010).	 The	 guideline	 includes	 the	
basic	 patho-physiology	 of	 acute	 pain,	 different	 types	 of	
pharmacological	 and	 non-pharmacological	 interventions	
for	 acute	 pain	 and	 various	 methods	 to	 deal	 with	 acute	
pain	 in	 d i fferent	 c l in ica l	 s i tua t ions .	 The	 document	
consists	 of	 490	 pages	 of	 evidence	 based	materials.	 The	
section	 on	 Summary of Key Messages allow	 users	 to	
revisit	 the	 main	 points	 covered	 in	 the	 Guideline	 at	 a	
glimpse.
Muscle Energy Techniques (MET)
http://www.mc.uky.edu/Athletic_training/docs/Modal
ityProject_MuscleEnergy_Spring2010.pdf
	 Musc le	 Energy	 Techn ique	 (MET)	 i s	 a	 k ind	 o f	
manipulat ive	 t reatment	 that	 a	 family	 physician	 can	
eas i ly	 prac t ice	 in	 h is	 own	 c l in ic .	 I t	 i s	 a	 s t re tching	
technique	 which	 facilitates	 relaxation	 of	 tight	 muscles,	
leading	 to	 rapid	 and	 effective	 reduction	 of	 pain.	 The	
article,	 with	 the	 help	 of	 video	 clips,	 provides	 a	 good	
introduction	 and	 working	 knowledge	 on	MET,	 allowing	
beg inners	 to	 ge t	 acqua in ted	 wi th	 the	 sk i l l se t	 ve ry	
readily.
The	Hong	Kong	Practitioner   		VOLUME	34				June		2012 87
Internet
Taping Techniques.com
http://www.tapingtechniques.com/
	 Acute	 f inger	 sprains,	 knee	 pain,	 foot	 and	 ankle	
sp ra in	 in ju r i e s	 a re	 common	 cond i t ions	 in	 gene ra l	
practice.	 Taping	 can	 be	 an	 easy	 yet	 effective	 way	 in	
dealing	 with	 these	 sports	 injuries.	 This	 website	 has	 a	
collection	 of	 videos	 showing	 different	 taping	methods	
for	 ankle ,	 foo t ,	 shoulder	 and	 back .	 There	 a re	 a l so	
cl inical	 photos	 which	 al low	 learners	 to	 pick	 up	 the	
technique	more	easily.	
Ankle Taping and Bracing
h t tp : / / emed i c ine .medscape . com/ar t i c l e / 86495 -
overview#a15
	 Ankle	 injuries	 in	 sports	 are	 very	 commonly	 seen	 in	
our	 everyday	practice.	For	patients	 prone	 to	develop	 ankle	
injury,	 taping	and	bracing	before	sports	engagement	can	be	
very	 useful.	 In	 this	 article,	 taping	 and	 bracing	 techniques	
of	 the	ankle	 joint	 are	 introduced	and	outlined.	The	content	
is	 very	 useful	 to	 family	 physicians	 interested	 in	 sports	
medicine,	 especially	when	 they	 are	 treating	 their	 patients	
or	giving	counselling	to	athletes.	n
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Classifieds
POSITIONS VACANT
FT/PT/Locum	 Fami ly Phys ic ian 	 (min .	 3	 yea r s ’	
experience)	 for	practices	of	United	Christian	Nethersole	
CHS	 in	NTW	 /	NTE	 /	Kowloon.	 Flexible	 hours.	 Please	
e-mai l	 resume	 with	 expected	 sa lary	 -	Ms. Law	 :	
hr@ucn.org.hk
****		 	 	 	****		 	 	 	****		 	 	 	****
Accredited Private FM Centre invites energetic 
Doctors	 for	 expanding	 services	 (Tuen	Mun	 /	 Kwai	
Fong) .	 Basic	 /	 h igher	 FM	 Trainee,	A&E	 Off icers	
welcomed.	 Basic	 +	 Profit	 Sharing	 ±	 Partnership.	 Send	
CV	enquiry@adecmed.com	(	Amy	CHAN)	9212	6654							
****		 	 	 	****		 	 	 	****		 	 	 	****
Assistant	 Doctor	 wanted	 by	 female	 doctor	 to	 perform	
esthetic	 procedures.	Will	 teach	 to	 do	 laser,	 botox,	
hya lu ron i c	 a c id	 and	 o the r	 e s t he t i c	 p rocedu re s ,	
including	 liposuction,	 11-8,	 six	 day	 a	 week,	 good	
remuneration.	 	 Sunday	 off.	 Interested	 please	 call	Miss	
Chu	9236	0591.
****		 	 	 	****		 	 	 	****		 	 	 	****
Female	Doctor	 needed	 by	 a	 laser	 and	 beauty	 clinic,	
good	working	 hours,	 Sunday	 and	 holiday	 off,	 120K	
per	month	 or	more,	 Interested	 please	 call	Miss	 Shek	
6902	0686.
****		 	 	 	****		 	 	 	****		 	 	 	****
FM	 trainee	 vacancy	 at	Ma	On	 Shan.	Musculoskeletal	
medicine	 training	 with	 excellent	 prospect.	 Flexible	
working	hours,	Basic	 salary	plus	bonus.	Tel:	 9016	2909	
or	email:	drandrewip@gmail.com
****		 	 	 	****		 	 	 	****		 	 	 	****
FT/PT	 GP,	 Various	 SP	 &	 Locum	 wanted	 by	 UMP	
Healthcare	Group.	Attractive	 remuneration	 packages.
Interested	 please	 email	 CV	 to	 hr@ump.com.hk	 or	 call	
HR	Dept.	at	2507	6916
****		 	 	 	****		 	 	 	****		 	 	 	****
CLINIC AVAILABLE
Yau	 Tong	 g r o und	 f l o o r 	 s h op	 f o r 	 r e n t 	 1 6 0 , 0 00	
population,	 low	 competition,	 facing	 new	 shopping	
center	“domain”	and	market.	3	minutes	walk	from	MTR	
station.	Call	Ms	Ng	6017	6156.
****		 	 	 	****		 	 	 	****		 	 	 	****


